Monoamine oxidase A inhibitors

MAOI_A

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AG 1 out of 7 registries used, show all original rules.	5279
4. Check minimum number of events Min. number of events 3	5279
5. Include endpoints None	5279
6. Filter based on genotype QC (FinnGen only)	5279

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MAOI_A
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AG
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Monoamine oxidase A inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5279	3199	2080
Unadjusted period prevalence (%)	1.02	1.09	0.92
Median age at first event (years)	44.40	43.51	45.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4784: Matched controls
47839

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

14.0

323.0

656

537

N05AH04

ATC

quetiapine; oral

22.3

323.0

1700

1154

C07AA05

ATC

propranolol; systemic

5.5

323.0

1548

3845

N05CD07

ATC

temazepam; oral

13.0

323.0

1327

1370

N03AE01

ATC

clonazepam; systemic

12.8

323.0

614

544

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.6

323.0

909

1423

N06AX12

ATC

bupropion; oral

127.5

323.0

762

N06AB05

ATC

paroxetine; oral

59.0

323.0

867

179

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

28.0

323.0

774

327

N06AB10

ATC

escitalopram; oral

30.4

323.0

1798

929

N06AX26

ATC

vortioxetine; oral

86.4

323.0

600

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

139.7

323.0

774

F34.1

ICD-10 Finland

Dysthymia

83.0

323.0

520

N06AB08

ATC

fluvoxamine; oral

81.1

323.0

496

N05AX08

ATC

risperidone; systemic

12.6

323.0

666

604

P76

ICPC

Depressive disorder

31.6

323.0

551

196

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

197.1

323.0

692

N06AB04

ATC

citalopram; systemic

38.3

323.0

2405

1228

P03

ICPC

Feeling depressed

12.3

323.0

629

583

N05AA02

ATC

levomepromazine; systemic

29.1

323.0

522

200

N06AX03

ATC

mianserin; oral

68.8

323.0

861

152

N05CF01

ATC

zopiclone; oral

6.3

323.0

2391

6514

N05BA12

ATC

alprazolam; oral

19.3

323.0

1363

965

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

65.9

323.0

780

141

F32.9

ICD-10 Finland

Depressive episode, unspecified

27.4

323.0

1229

595

N05AB03

ATC

perphenazine; systemic, rectal

26.5

323.0

472

197

N05BA04

ATC

oxazepam; oral

12.1

323.0

2355

3542

N05BE01

ATC

buspirone; oral

71.1

323.0

549

N06AA12

ATC

doxepin; systemic

31.5

323.0

639

233

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

19.5

323.0

895

558

N05AH03

ATC

olanzapine; systemic

22.7

323.0

623

313

N06AX16

ATC

venlafaxine; oral

63.5

323.0

1755

432

N06AX11

ATC

mirtazapine; oral

14.0

323.0

2602

3747

N06AB06

ATC

sertraline; oral

56.3

323.0

1406

351

N05BA01

ATC

diazepam; systemic, rectal

9.7

323.0

1382

1914

N06AX21

ATC

duloxetine; oral

22.5

323.0

1074

607

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

131.9

323.0

539

N06AG02

ATC

moclobemide; oral

+∞

323.0

4784

131

N03AX09

ATC

lamotrigine; oral

31.4

323.0

540

193

N06AB03

ATC

fluoxetine; oral

43.2

323.0

1752

631

N06AA09

ATC

amitriptyline; systemic

10.8

323.0

838

926

N05CF02

ATC

zolpidem; oral

4.9

320.0

1208

3066

F32.1

ICD-10 Finland

Moderate depressive episode

21.5

319.0

481

247

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

12.1

310.1

594

555

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

97.0

302.8

334

N05BA06

ATC

lorazepam; systemic, sublingual

15.6

299.5

510

364

N03AG01

ATC

valproic acid; systemic, rectal

11.8

295.8

572

543

N05AF03

ATC

chlorprothixene; systemic

41.3

293.5

371

N05AX12

ATC

aripiprazole; systemic

32.1

291.7

391

132

N06AA06

ATC

trimipramine; systemic

56.4

286.2

341

N06AX05

ATC

trazodone; oral

89.1

283.5

316

F32

ICD-10 Finland

Depressive episode

22.2

282.8

422

208

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

216.3

277.1

285

F40.1

ICD-10 Finland

Social phobias

72.1

276.5

317

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.6

276.4

410

198

N06AX18

ATC

reboxetine; oral

266.1

271.7

276

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.6

270.7

628

827

F41.1

ICD-10 Finland

Generalized anxiety disorder

22.6

264.6

392

188

N05AF01

ATC

flupentixol; systemic

58.1

257.3

305

N05AN01

ATC

lithium; oral

35.8

253.7

331

N06AA04

ATC

clomipramine; systemic

98.6

245.1

270

P01

ICPC

Feeling anxious/nervous/tense

7.7

235.5

586

854

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

100.6

233.8

257

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

82.4

228.2

257

N05AL01

ATC

sulpiride; systemic

59.8

225.5

266

SPAT1240

SPAT

Therapeutic discussion

6.4

224.2

641

1133

N03AX16

ATC

pregabalin; oral

3.3

224.1

1387

5233

F61.0

ICD-10 Finland

Mixed personality disorders

88.7

218.7

244

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

24.9

214.5

308

132

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

33.1

211.5

281

N06AX22

ATC

agomelatine; oral

103.6

207.1

227

F51.0

ICD-10 Finland

Nonorganic insomnia

4.7

198.0

743

1790

N05BA02

ATC

chlordiazepoxide; systemic

25.1

197.1

282

119

N07BB01

ATC

disulfiram; oral

13.6

196.7

353

279

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

94.2

195.0

216

N06AX17

ATC

milnacipran; oral

329.8

190.8

192

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

35.2

184.2

241

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

14.7

178.4

309

224

P29

ICPC

Psychological sympt/compl other

9.1

170.7

377

446

P74

ICPC

Anxiety disorder/anxiety state

18.2

168.0

267

155

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.8

167.2

448

714

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

64.8

165.7

193

F31.8

ICD-10 Finland

Other bipolar affective disorders

67.1

156.3

181

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

33.4

152.6

202

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

94.9

149.1

165

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

148.5

1321

6042

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

86.0

148.2

166

R53

ICD-10 Finland

Malaise and fatigue

2.9

147.2

1052

4205

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

29.8

146.8

200

F33

ICD-10 Finland

Recurrent depressive disorder

83.9

144.2

162

N06AA22

ATC

130.7

142.0

152

P99

ICPC

Psychological disorders other

18.4

139.3

220

125

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

134.9

144

F60.9

ICD-10 Finland

Personality disorder, unspecified

78.0

133.2

151

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

32.6

130.1

173

N05CD02

ATC

nitrazepam; oral

18.7

126.8

199

111

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

123.1

599

1788

N03AX12

ATC

gabapentin; oral

3.0

122.7

808

3023

F10.20

ICD-10 Finland

Alcohol dependence currently independent

25.9

122.5

173

A02BA02

ATC

ranitidine; systemic

2.6

119.7

1083

4910

N05AC02

ATC

thioridazine; oral

15.8

117.8

197

130

P06

ICPC

Sleep disturbance

3.9

117.6

539

1526

A06AD11

ATC

lactulose; oral

3.2

116.2

703

2473

SPAT1307

SPAT

Psychosocial counselling and guidance

6.6

114.1

310

498

A02BC01

ATC

omeprazole; systemic

2.3

113.1

1386

7304

G47.3

ICD-10 Finland

Sleep apnoea

2.5

112.6

1100

5176

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

32.0

111.7

149

F41.09

ICD-10 Finland

UNS Panic Syndrome

19.3

111.6

173

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

46.9

111.6

137

A02BC02

ATC

pantoprazole; systemic

2.0

110.4

3080

22709

F41.00

ICD-10 Finland

Moderate panic disorder

44.0

110.2

137

A03CA02

ATC

clidinium and psycholeptics; oral

4.5

110.1

416

982

F29

ICD-10 Finland

Unspecified nonorganic psychosis

10.3

110.0

224

227

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

43.6

109.2

136

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

57.6

108.9

129

N05AB01

ATC

dixyrazine; systemic

28.6

107.0

147

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

73.4

106.9

122

F31

ICD-10 Finland

Bipolar affective disorder

52.1

105.5

127

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

104.6

1663

9762

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

14.1

104.0

182

134

A02BC03

ATC

lansoprazole; oral

2.1

103.3

1469

8215

N05BA05

ATC

potassium clorazepate; oral

40.5

102.8

130

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

182.3

102.7

107

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

28.8

102.2

140

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

30.0

101.1

137

IGY99

NOMESCO Finland

Other psychiatric treatment contact

39.8

100.9

128

N02AX02

ATC

tramadol; systemic, rectal

2.0

99.8

1988

12697

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.5

98.5

269

434

N05AD03

ATC

melperone; systemic

22.5

96.6

142

R06.0

ICD-10 Finland

Dyspnoea

2.2

96.4

1182

6149

IGY02

NOMESCO Finland

Psychiatric monitoring contact

21.3

95.6

143

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

106.3

95.3

104

A02BC05

ATC

esomeprazole; systemic

1.9

92.6

1946

12574

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

21.7

92.1

137

V03AA01

ATC

14.0

90.4

158

116

H03AA01

ATC

levothyroxine sodium; systemic

2.2

90.4

1193

6389

AA400

NOMESCO Finland

Electroconvulsive therapy

123.7

90.3

R03AC02

ATC

salbutamol; inhalant

1.9

90.1

2430

17094

F99

ICD-10 Finland

Mental disorder, not otherwise specified

14.4

90.1

156

112

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

88.4

1829

11691

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

37.3

87.9

113

N06AA10

ATC

nortriptyline; systemic

13.2

87.3

157

123

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

29.2

85.9

117

A03FA02

ATC

cisapride; oral, rectal

3.4

84.7

456

1455

SPAT1243

SPAT

Psychiatric/psychological examination

12.0

84.7

159

137

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

80.8

84.4

A04

ICPC

Weakness/tiredness general

2.8

82.4

598

2336

M03BX02

ATC

tizanidine; oral

1.8

80.4

2905

22135

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.4

79.9

414

1281

N06BA04

ATC

methylphenidate; oral

19.2

79.0

122

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

78.5

1259

7238

F32.8

ICD-10 Finland

Other depressive episodes

25.2

78.3

111

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

78.3

1332

7834

F60.5

ICD-10 Finland

Anankastic personality disorder

48.4

78.0

N04AA02

ATC

biperiden; systemic

11.2

76.4

148

136

C07AB07

ATC

bisoprolol; oral

1.8

76.3

2084

14423

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

75.9

715

3228

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

19.5

75.5

116

F41.8

ICD-10 Finland

Other specified anxiety disorders

10.8

75.0

148

141

N03AF01

ATC

carbamazepine; oral, rectal

4.2

74.0

297

737

P15

ICPC

Chronic alcohol abuse

8.6

73.8

166

200

J02AC01

ATC

fluconazole; systemic

1.8

73.6

1894

12811

A02BA04

ATC

nizatidine; systemic

3.1

72.1

432

1483

F33.8

ICD-10 Finland

Other recurrent depressive disorders

152.3

71.1

F61

ICD-10 Finland

Mixed and other personality disorders

97.8

70.1

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

69.9

1320

8004

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

69.4

2085

14715

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

73.1

69.3

M79.7

ICD-10 Finland

Fibromyalgia

6.8

69.2

181

275

F39

ICD-10 Finland

Unspecified mood [affective] disorder

17.6

69.1

110

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

45.5

69.1

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.8

68.8

310

853

N03AX11

ATC

topiramate; oral

8.7

68.3

152

180

N05AA01

ATC

chlorpromazine; systemic, rectal

14.0

68.3

119

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

39.8

68.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.7

67.9

205

375

N02BE01

ATC

paracetamol; systemic, rectal

1.9

67.5

3968

34260

M54.5

ICD-10 Finland

Low back pain

1.8

67.3

1439

9088

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

14.3

67.2

116

P01AB01

ATC

metronidazole; oral, rectal

1.7

65.4

1823

12502

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

11.8

65.3

123

107

N05AD01

ATC

haloperidol; systemic

6.7

64.9

172

266

N05CD08

ATC

midazolam; nasal, systemic

7.7

64.1

153

203

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

30.2

63.9

F10.24

ICD-10 Finland

Alcohol depence active use

15.2

63.1

106

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

5.3

63.0

200

388

J01DA01

ATC

[U] cefalexin; systemic

1.7

62.8

2874

22640

L03

ICPC

Low back symptom/complaint

1.9

62.6

1053

6080

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.6

62.2

118

104

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

133.8

62.0

M01AE02

ATC

naproxen; oral, rectal

1.7

62.0

2525

19221

L28

ICPC

Limited function/disability (L)

2.3

61.9

652

3090

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.4

61.7

118

106

G44.2

ICD-10 Finland

Tension-type headache

2.4

61.6

604

2763

R06AE07

ATC

cetirizine; oral

1.7

61.0

1939

13741

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

60.8

745

3782

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

60.7

2364

17730

WX110

NOMESCO Finland

Local anesthesy

1.7

60.5

3065

24703

M79.6

ICD-10 Finland

Pain in limb

1.7

59.9

1559

10396

N05AB02

ATC

fluphenazine; systemic

25.6

59.0

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

11.9

58.9

110

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

58.9

795

4200

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

58.8

3133

25494

F90.0

ICD-10 Finland

Disturbance of activity and attention

11.8

58.1

109

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

25.2

58.1

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

11.5

57.3

109

V03AB30

ATC

22.8

57.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

56.6

963

5555

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

56.4

391

1471

Z71.8

ICD-10 Finland

Other specified counselling

1.9

55.9

1039

6181

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

121.5

55.9

F60.8

ICD-10 Finland

Other specific personality disorders

55.7

AA1AD

NOMESCO Finland

CT of head and brain

1.9

55.7

985

5761

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

55.5

1818

12886

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

284.7

55.3

R51.80

ICD-10 Finland

Headache

2.2

54.6

612

2974

R42

ICD-10 Finland

Dizziness and giddiness

1.9

54.2

926

5341

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

17.5

54.2

188

Kela drug reimbursment

Psychosis requiring demanding treatment

18.7

53.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

53.5

305

1007

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

185.4

53.0

K02.1

ICD-10 Finland

Caries of dentine

1.6

53.0

2451

18954

F32.0

ICD-10 Finland

Mild depressive episode

8.0

52.9

123

157

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.7

52.8

389

1518

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

16.7

52.1

C03CA01

ATC

furosemide; systemic

1.8

52.0

1095

6772

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

41.1

52.0

J01EA01

ATC

trimethoprim; systemic

1.8

51.9

1100

6819

R06.5

ICD-10 Finland

Mouth breathing

2.5

51.5

429

1793

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

48.3

51.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

51.1

936

5518

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

51.0

497

2253

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

178.5

51.0

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

50.4

704

3751

R01AD09

ATC

mometasone; nasal

1.6

50.3

1968

14509

G04BD04

ATC

oxybutynin; oral, transdermal

3.3

50.3

271

858

N04BC05

ATC

pramipexole; oral

2.9

50.3

334

1221

N05AC01

ATC

periciazine; systemic

65.1

50.3

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

175.1

50.0

N05AE04

ATC

ziprasidone; systemic

50.6

49.9

L02

ICPC

Back symptom/complaint

2.6

49.9

407

1682

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

49.8

1587

11078

J01MA02

ATC

ciprofloxacin; systemic

1.6

49.8

1666

11780

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

49.4

2089

15687

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

252.7

49.1

L01

ICPC

Neck symptom/complaint

2.1

49.0

607

3072

WX290

NOMESCO Finland

Other blockade of nerve

1.6

48.6

1862

13616

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

48.4

599

3028

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

48.4

1986

14772

SPAT1234

SPAT

Support of social functional capacity

3.8

48.1

212

572

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

105.1

47.8

N06AC02

ATC

42.6

47.6

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

8.6

47.2

105

125

E0000UV

ATC

1.6

46.8

1683

12074

P20

ICPC

Memory disturbance

2.4

46.8

442

1972

A01

ICPC

Pain general/multiple sites

2.7

46.8

341

1319

F41.3

ICD-10 Finland

Other mixed anxiety disorders

17.5

46.7

IHZ05

SPAT

10.3

46.4

T82

ICPC

Obesity

4.0

46.3

194

500

N05AH02

ATC

clozapine; systemic

9.4

46.1

105

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

16.2

46.0

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

45.9

2507

19889

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

50.5

45.8

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.9

45.7

113

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

45.6

1036

6525

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

45.5

1223

8098

R01AD08

ATC

fluticasone; nasal

1.7

45.2

1256

8389

R4110

NOMESCO Finland

Physiotherapy

1.7

45.1

1165

7621

J01AA02

ATC

doxycycline; systemic

1.6

45.0

3562

30813

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

44.7

362

1484

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

44.6

2384

18763

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

44.4

657

3565

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

44.0

1714

12493

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

19.4

43.9

R03BA02

ATC

budesonide; inhalant

1.9

43.8

750

4291

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

33.9

43.8

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

33.9

43.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

43.7

2742

22342

D01

ICPC

Abdominal pain/cramps general

2.3

43.6

447

2072

F60.7

ICD-10 Finland

Dependent personality disorder

52.5

43.6

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

43.5

332

1319

J01FA06

ATC

roxithromycin; oral

1.6

43.4

1796

13275

KMAK

NOMESCO Finland

1.5

43.2

2242

17469

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

63.1

43.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

20.9

43.1

M01AX17

ATC

nimesulide; oral

1.7

43.0

1088

7058

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

42.8

542

2758

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

42.8

1416

9888

M02AA07

ATC

piroxicam; topical

1.6

42.8

1599

11517

R02

ICPC

Shortness of breath/dyspnoea

2.2

42.6

495

2428

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

42.5

343

1406

G04CA02

ATC

tamsulosin; oral

1.8

42.3

820

4894

R4140

NOMESCO Finland

Psychotherapy

32.7

41.9

R06AX13

ATC

loratadine; oral

1.9

41.9

682

3830

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.2

41.8

104

148

UJF32

NOMESCO Finland

Coloscopy

1.7

41.8

1104

7241

R03BB04

ATC

tiotropium bromide; inhalant

2.3

41.7

406

1835

D11

ICPC

Diarrhoea

2.2

41.6

452

2153

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

41.5

1394

9755

EBA00

NOMESCO Finland

Extraction of tooth

1.6

41.2

1334

9241

M01AH01

ATC

celecoxib; oral (coxibs)

1.8

41.2

781

4622

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

41.1

560

2938

M01AB05

ATC

diclofenac; systemic, rectal

1.5

41.0

2980

24913

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.3

41.0

393

1760

L17

ICPC

Foot/toe symptom/complaint

1.7

40.9

1031

6666

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

40.7

1176

7897

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

40.7

983

6273

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

40.7

1659

12167

C05AA08

ATC

fluocortolone; rectal, topical

1.9

40.5

660

3703

P16

ICPC

Acute alcohol abuse

9.2

40.5

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

30.3

40.5

N05CD05

ATC

triazolam; oral, sublingual

8.5

40.4

108

E66.8

ICD-10 Finland

Other obesity

3.0

40.4

242

824

E000001

ATC

1.8

40.3

845

5160

J01DB01

ATC

cefalexin; oral

1.6

40.3

3649

32037

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

15.5

40.0

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

75.8

39.9

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

39.9

421

1974

R03AC03

ATC

terbutaline; inhalant

1.9

39.8

610

3344

R52.2

ICD-10 Finland

Other chronic pain

4.2

39.8

155

374

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

39.8

1179

7966

K59.0

ICD-10 Finland

Constipation

3.0

39.8

245

851

F41.01

ICD-10 Finland

Severe panic disorder

108.4

39.8

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

39.1

261

955

P28

ICPC

Limited function/disability (P)

17.0

38.9

J01MA06

ATC

norfloxacin; oral

1.9

38.8

613

3396

A01AB09

ATC

miconazole; local oral

2.2

38.6

403

1881

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

38.6

678

3902

C07AB02

ATC

metoprolol; systemic

1.8

38.6

833

5129

G04BD07

ATC

tolterodine; oral

3.0

38.6

236

817

R05FB02

ATC

cough suppressants and expectorants

1.5

38.3

1664

12342

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

38.2

1781

13415

H02AB06

ATC

prednisolone; systemic

1.5

38.2

1956

15047

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.8

38.1

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

25.5

38.0

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.0

37.9

107

181

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

37.9

506

2626

P72

ICPC

Schizophrenia

7.5

37.9

123

M01AC06

ATC

meloxicam; systemic, rectal

1.5

37.9

1593

11713

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

84.8

37.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

37.7

789

4808

R35

ICD-10 Finland

Polyuria

2.7

37.7

276

1068

M25.5

ICD-10 Finland

Pain in joint

1.6

37.6

1205

8287

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

37.5

911

5809

R03DC03

ATC

montelukast; oral

1.8

37.4

677

3934

SPAT1301

SPAT

No procedures

1.6

37.4

1282

8969

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

37.3

1117

7543

Z01.2

ICD-10 Finland

Dental examination

1.5

37.3

1720

12906

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

36.7

861

5427

A28

ICPC

Limited function/disability NOS

2.0

36.5

520

2768

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.4

36.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

36.3

871

5526

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.8

36.2

105

184

P25

ICPC

Phase of life problem adult

3.7

36.2

167

469

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

35.9

719

4315

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

35.8

665

3894

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

35.8

661

3860

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

35.8

522

2804

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

35.8

1715

12943

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

98.3

35.7

A02BA03

ATC

famotidine; systemic

3.2

35.7

192

608

S06.0

ICD-10 Finland

Concussion

2.2

35.6

404

1957

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

35.6

716

4301

A07DA03

ATC

loperamide; oral

3.3

35.5

188

588

A10BA02

ATC

metformin; oral

1.6

35.4

1101

7495

L08

ICPC

Shoulder symptom/complaint

1.7

35.3

809

5061

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.9

34.9

F21

ICD-10 Finland

Schizotypal disorder

22.9

34.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

34.8

1222

8569

G04BD12

ATC

mirabegron; oral

2.1

34.8

413

2039

L15

ICPC

Knee symptom/complaint

1.7

34.7

877

5637

D07AA02

ATC

hydrocortisone; topical

1.9

34.7

551

3052

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

34.7

447

2284

IBA03

NOMESCO Finland

Psychotherapy evaluation

27.9

34.6

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

34.5

1117

7675

309

Kela drug reimbursment

Nalmefene and naltrexone

32.4

34.4

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

34.3

842

5367

M79.1

ICD-10 Finland

Myalgia

1.9

34.3

529

2897

SPAT1241

SPAT

Extensive assessment of psychosocial situation

12.0

34.3

R52.9

ICD-10 Finland

Pain, unspecified

2.2

34.1

355

1653

-1

NOMESCO Finland

1.5

34.0

1333

9589

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

339.5

33.9

A06AC51

ATC

ispaghula, combinations; systemic

2.8

33.8

234

876

N02AA05

ATC

oxycodone; systemic

1.9

33.8

529

2914

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

45.9

33.7

T90

ICPC

Diabetes non-insulin dependent

1.6

33.7

923

6063

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

33.7

385

1870

J01CA04

ATC

amoxicillin; systemic

1.5

33.6

3539

31262

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

33.5

819

5209

R06AX27

ATC

desloratadine; oral

1.6

33.5

1097

7550

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.3

33.4

126

296

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

33.3

811

5152

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

33.3

982

6576

P73

ICPC

Affective psychosis

23.7

33.1

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

32.8

1728

13242

J01FA10

ATC

azithromycin; systemic

1.4

32.7

2483

20465

R03BA01

ATC

beclometasone; inhalant

1.8

32.7

599

3483

30041

ICD-8 Finland

Neuroses, Depressiva

7.5

32.7

105

R05

ICPC

Cough

1.6

32.6

911

6007

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

32.6

432

2231

M01AB55

ATC

diclofenac, combinations; oral

2.3

32.3

314

1413

IGY02

SPAT

21.6

32.1

R11

ICD-10 Finland

Nausea and vomiting

2.3

32.1

306

1367

UKC02

NOMESCO Finland

Cystoscopy

1.8

31.9

609

3588

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.4

31.9

285

1231

H02AB07

ATC

prednisone; oral

1.8

31.8

596

3492

R06AX22

ATC

ebastine; oral

1.7

31.7

742

4656

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.7

31.7

143

395

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

31.7

497

2737

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

31.6

1085

7534

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

31.4

1036

7128

J01AA07

ATC

tetracycline; systemic

1.8

31.3

642

3866

D07AC01

ATC

betamethasone; topical

1.5

31.1

1399

10336

R07.3

ICD-10 Finland

Other chest pain

2.0

30.8

397

2026

R05

ICD-10 Finland

Cough

1.7

30.7

804

5200

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

30.7

873

5773

J01DA06

ATC

[U] cefuroxime; systemic

1.8

30.6

629

3793

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

30.4

548

3163

SPAT1053

SPAT

Memory test

1.9

30.4

523

2974

N01

ICPC

Headache

2.1

30.3

357

1754

E66.9

ICD-10 Finland

Obesity, unspecified

3.4

30.3

152

457

R01AD01

ATC

beclometasone; nasal

1.7

30.3

662

4064

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

30.3

1042

7234

M01AH02

ATC

rofecoxib; oral

1.8

30.2

548

3170

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

27.5

30.1

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

30.1

2948

25313

A02BX02

ATC

sucralfate; oral

2.9

30.1

186

649

G03DB01

ATC

dydrogesterone; oral

1.8

30.1

552

3206

XKD00

NOMESCO Finland

Uroflowmetry

1.8

29.9

573

3375

SPAT1252

SPAT

Overall medication plan or its review

2.3

29.9

280

1237

P80

ICPC

Personality disorder

68.3

29.9

R03BA05

ATC

fluticasone; inhalant

1.7

29.9

735

4669

D12

ICPC

Constipation

3.6

29.8

137

385

C10AA01

ATC

simvastatin; oral

1.4

29.7

1710

13261

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

29.7

1718

13341

WZA90

NOMESCO Finland

Other doctors statement

1.6

29.6

909

6129

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

45.3

29.6

N05BB01

ATC

hydroxyzine; systemic

2.4

29.6

272

1190

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

7.9

29.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

29.5

335

1620

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

29.4

567

3344

M02AA10

ATC

ketoprofen; topical

1.7

29.3

670

4167

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

29.2

623

3797

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

29.1

1142

8159

F22.0

ICD-10 Finland

Delusional disorder

6.8

29.1

110

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

29.1

233

948

R74

ICPC

Upper respiratory infection acute

1.5

29.0

1074

7574

N03AF02

ATC

oxcarbazepine; oral

3.6

29.0

135

383

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

29.0

518

2979

N02AC04

ATC

dextropropoxyphene; oral

3.0

29.0

173

590

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

11.1

29.0

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

40.3

28.9

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

28.1

28.8

IER01

NOMESCO Finland

Psychoeducation, group

28.1

28.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

28.8

292

1341

N17

ICPC

Vertigo/dizziness

1.9

28.8

426

2294

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

80.6

28.8

2961A

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]

80.6

28.8

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

28.5

173

597

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

28.5

1018

7114

IEY01

NOMESCO Finland

Psychoeducation, individual

29.4

28.5

SPAT1254

SPAT

Administration of medicine

1.8

28.4

499

2852

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

23.7

28.2

TAB00

NOMESCO Finland

Lumbar puncture

2.8

28.2

190

701

S18

ICPC

Laceration/cut

1.4

28.1

1700

13275

M54

ICD-10 Finland

Dorsalgia

1.9

28.1

445

2455

A01AB04

ATC

amphotericin B; local oral

2.6

28.0

217

869

SPAT1310

SPAT

Counselling related to known health issue

1.5

27.9

1273

9390

SPAT1216

SPAT

Assessment of functional ability

1.8

27.7

552

3287

K30

ICD-10 Finland

Functional dyspepsia

1.9

27.7

435

2393

N05AF05

ATC

zuclopenthixol; systemic

8.4

27.7

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

100.6

27.7

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

145.8

27.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

27.6

953

6599

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

27.5

627

3890

S29

ICPC

Skin symptom/complaint other

1.7

27.5

677

4296

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

27.4

864

5849

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

27.2

257

1140

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

53.6

27.2

SPAT1235

SPAT

Mental health, emotional support

15.9

27.1

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

27.1

206

816

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

27.1

183

676

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

62.4

26.9

R21

ICPC

Throat symptom/complaint

1.6

26.9

718

4653

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

26.9

1531

11790

N06AA21

ATC

maprotiline; systemic

272.5

26.7

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

8.4

26.7

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

9.4

26.6

M01AE51

ATC

ibuprofen, combinations; systemic

4.6

26.6

208

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

24.8

26.5

R25.1

ICD-10 Finland

Tremor, unspecified

3.4

26.2

132

399

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

26.2

1328

9979

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.4

26.2

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

52.0

26.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

26.1

163

574

ICD-10 Finland

3.5

26.1

125

364

IGV01

NOMESCO Finland

Psychiatric network contact

19.6

26.0

A97

ICPC

No disease

1.7

25.9

578

3559

M01AH05

ATC

etoricoxib; oral

1.4

25.9

2512

21245

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

25.9

302

1476

N07BA03

ATC

varenicline; oral

2.5

25.9

210

861

N30.0

ICD-10 Finland

Acute cystitis

1.8

25.8

513

3050

F51

ICD-10 Finland

Nonorganic sleep disorders

3.4

25.8

128

383

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.5

25.7

206

SPAT1265

SPAT

Breathalyser

9.4

25.6

SPAT1260

SPAT

Consultation of another employee

1.6

25.5

683

4425

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

25.5

878

6062

R96

ICPC

Asthma

2.0

25.5

348

1813

U02

ICPC

Urinary frequency/urgency

1.8

25.4

511

3050

R06AX26

ATC

fexofenadine; oral

2.1

25.4

296

1447

J01CA08

ATC

pivmecillinam; oral

1.4

25.4

1583

12371

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

25.3

366

1951

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

25.3

1073

7761

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

25.3

2336

19555

M48.0

ICD-10 Finland

Spinal stenosis

1.8

25.3

444

2534

U04

ICPC

Incontinence urine

2.7

25.2

176

665

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

25.1

758

5066

P58

ICPC

Psychological, Therapeutic counselling/listening

7.0

25.1

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

6.1

25.0

115

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

9.2

24.9

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

70.2

24.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

24.7

164

600

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

32.2

24.6

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

24.6

140

462

L29

ICPC

Musculoskeletal sympt/complt other

2.1

24.5

303

1515

C08CA01

ATC

amlodipine; oral

1.4

24.5

1377

10537

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

24.4

287

1407

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

24.3

242

M03BX01

ATC

baclofen; systemic

5.2

24.3

148

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

48.6

24.3

N05AB04

ATC

prochlorperazine; systemic, rectal

3.5

24.2

117

343

J01FF01

ATC

clindamycin; systemic

1.5

24.2

1070

7796

F41

ICD-10 Finland

Other anxiety disorders

7.2

24.2

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

24.2

183

723

L13

ICPC

Hip symptom/complaint

1.7

24.1

610

3889

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

29.3

24.0

F60.0

ICD-10 Finland

Paranoid personality disorder

56.3

24.0

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

11.7

23.9

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

22.8

23.8

G04BD08

ATC

solifenacin; oral

2.2

23.8

254

1192

R01AD05

ATC

budesonide; nasal

2.0

23.8

335

1765

N05AE05

ATC

lurasidone; oral

87.2

23.7

J45

ICD-10 Finland

Asthma

1.9

23.6

379

2098

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

23.6

481

2877

N06AE02

ATC

125.6

23.6

D19

ICPC

Teeth/gum symptom/complaint

1.5

23.5

1020

7397

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

8.3

23.5

G25.0

ICD-10 Finland

Essential tremor

3.4

23.5

115

341

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

23.5

2073

17140

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

21.4

23.4

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

23.4

215

942

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.1

23.2

132

435

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

23.2

298

1519

R60.0

ICD-10 Finland

Localized oedema

1.8

23.0

415

2388

A07AA02

ATC

nystatin; oral

2.2

23.0

251

1193

K07.60

ICD-10 Finland

Snapping jaw

2.5

23.0

184

752

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

23.0

392

2217

C10AA05

ATC

atorvastatin; oral

1.4

22.9

1499

11760

R51

ICD-10 Finland

Headache

2.4

22.9

197

834

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

22.8

262

1273

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

22.8

254

1216

A03DA02

ATC

pitofenone and analgesics; systemic

3.7

22.8

101

277

A99

ICPC

Disease/condition unspecnature/site

2.0

22.7

300

1545

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

11.4

22.6

SPAT1238

SPAT

Brief therapy

6.0

22.6

107

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

22.6

192

807

ZXA00

NOMESCO Finland

Right side

1.5

22.5

1081

7993

RS221

NOMESCO Finland

4.5

22.5

179

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.8

22.4

112

V03AA02

ATC

45.2

22.3

N07BB04

ATC

naltrexone; oral

45.2

22.3

SPAT1312

SPAT

General health counselling

1.4

22.1

1234

9390

R01AD12

ATC

fluticasone furoate; nasal

1.4

22.1

1153

8665

Z08

ICPC

Social welfare problem

6.7

22.1

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

9.9

22.0

SPAT1229

SPAT

Assessment of need for aid

2.0

21.9

282

1436

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

21.9

101

286

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.3

21.9

206

915

N05AA03

ATC

promazine; systemic

62.8

21.8

F34.0

ICD-10 Finland

Cyclothymia

62.8

21.8

U05

ICPC

Urination problems other

2.5

21.8

179

742

J01MA12

ATC

levofloxacin; systemic

1.6

21.8

683

4595

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

21.7

1909

15709

Z72.1

ICD-10 Finland

Alcohol use

6.4

21.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

21.6

362

2032

ZXA05

NOMESCO Finland

Left side

1.5

21.6

1005

7375

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

220.9

21.6

F60.1

ICD-10 Finland

Schizoid personality disorder

43.5

21.4

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

43.5

21.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

21.3

681

4598

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

21.3

130

452

J02AC02

ATC

itraconazole; systemic

1.5

21.3

739

5088

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

15.5

21.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

20.9

428

2564

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

20.9

992

7302

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

16.6

20.9

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

24.3

20.8

K08.3

ICD-10 Finland

Retained dental root

2.0

20.8

264

1337

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

37.3

20.7

L16

ICPC

Ankle symptom/complaint

1.8

20.7

372

2140

E03

ICD-10 Finland

Other hypothyroidism

2.1

20.6

232

1119

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

20.5

720

4967

D82

ICPC

Teeth/gum disease

1.4

20.4

1334

10420

P18

ICPC

Medication abuse

20.1

20.3

R4120

NOMESCO Finland

Occupational therapy

2.1

20.3

241

1187

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

20.3

400

2366

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

20.3

365

2097

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

20.3

215

1009

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

20.3

141

532

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

20.3

315

1723

XKC03

NOMESCO Finland

Water cystometry

2.8

20.2

130

468

N02CC03

ATC

zolmitriptan; nasal, oral

2.2

20.2

202

924

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

20.1

4033

37638

U01

ICPC

Dysuria/painful urination

2.0

20.1

272

1414

WX002

NOMESCO Finland

Sedation and analgesia

1.5

20.1

755

5290

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

20.0

210

980

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

19.9

538

3478

A27

ICPC

Fear of other disease NOS

2.4

19.9

173

739

X15

ICPC

Vaginal symptom/complaint other

3.0

19.8

117

399

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

19.8

509

3252

D07AD01

ATC

clobetasol; topical

1.6

19.7

623

4191

A02BC04

ATC

rabeprazole; oral

1.8

19.7

329

1842

-50

ICPC

Medication/prescr/renewal

2.4

19.6

164

684

SPAT1281

SPAT

Other administrative function

1.9

19.6

286

1528

G01AF05

ATC

econazole; vaginal

1.8

19.6

328

1839

P27

ICPC

Fear of mental disorder

7.5

19.6

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.1

19.6

108

352

3016A

ICD-9 Finland

Personality disorders, Dependent personality disorder

105.4

19.6

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.7

19.5

456

2836

D01AC02

ATC

miconazole; topical

1.9

19.5

305

1670

F20.0

ICD-10 Finland

Paranoid schizophrenia

12.1

19.5

F50.2

ICD-10 Finland

Bulimia nervosa

24.7

19.5

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

19.5

285

1524

Z72.2

ICD-10 Finland

Drug use

19.4

19.5

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

19.5

1814

14977

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

19.5

927

6818

C08DA01

ATC

verapamil; systemic

2.4

19.4

163

683

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

19.4

488

3099

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

19.4

380

2244

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

19.4

300

1639

C07AB03

ATC

atenolol; systemic

2.1

19.4

223

1086

D07AC13

ATC

mometasone; topical

1.4

19.2

1129

8632

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

19.2

160

669

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

19.2

584

3890

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

19.2

472

2978

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

19.2

478

3026

H01

ICPC

Ear pain/earache

1.7

19.2

378

2235

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

3.2

19.2

100

313

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

8.0

19.2

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

4.9

19.1

131

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

26.1

19.1

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

19.1

223

1093

Z01.7

ICD-10 Finland

Laboratory examination

1.7

19.0

422

2586

F50.9

ICD-10 Finland

Eating disorder, unspecified

12.2

19.0

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

19.0

189

864

P98

ICPC

Psychosis NOS/other

11.4

18.9

2961B

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]

55.2

18.9

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

55.2

18.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

18.8

278

1491

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

18.8

292

1597

R06AE09

ATC

levocetirizine; oral

1.6

18.8

550

3632

WX780

NOMESCO Finland

Remote monitoring CPAP

2.4

18.7

160

678

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

18.7

192

888

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

18.7

211

1018

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

3.1

18.6

106

351

S21

ICPC

Skin texture symptom/complaint

1.6

18.6

459

2899

IAB01

SPAT

100.4

18.6

F34.8

ICD-10 Finland

Other persistent mood [affective] disorders

100.4

18.6

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

100.4

18.6

G72.8

ICD-10 Finland

Other specified myopathies

5.2

18.5

110

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

18.5

436

2718

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

18.4

261

1380

S01.0

ICD-10 Finland

Open wound of scalp

2.0

18.4

252

1315

F05.9

ICD-10 Finland

Delirium, unspecified

4.5

18.4

146

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

18.3

660

4570

L12

ICPC

Hand/finger symptom/complaint

1.6

18.3

511

3332

R52.1

ICD-10 Finland

Chronic intractable pain

7.2

18.2

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

18.2

223

1113

F20

ICD-10 Finland

Schizophrenia

11.0

18.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

18.1

238

1224

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

18.1

204

983

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

18.1

1453

11686

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

9.8

18.1

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

18.0

243

1262

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

52.7

17.9

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

17.9

1282

10122

SPAT1139

SPAT

Nutrition survey

2.7

17.9

126

478

WX722

NOMESCO Finland

PEEP

2.2

17.8

178

813

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

17.8

377

2278

Z00.0

ICD-10 Finland

General medical examination

1.5

17.8

673

4713

T83

ICPC

Overweight

3.6

17.8

229

A29

ICPC

General symptom/complaint other

1.7

17.7

393

2407

T43.0

ICD-10 Finland

Poisoning: Tricyclic and tetracyclic antidepressants

+∞

17.7

N06AX

ATC

Other antidepressants

+∞

17.7

A08

ICPC

Swelling

2.4

17.7

153

654

F50.8

ICD-10 Finland

Other eating disorders

36.8

17.6

F45.0

ICD-10 Finland

Somatization disorder

12.5

17.6

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.2

17.6

179

827

SPAT1058

SPAT

PEF monitoring instruction

1.8

17.5

314

1802

A09

ICPC

Sweating problem

5.1

17.5

109

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

17.4

1021

7785

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

17.4

165

737

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

28.9

17.4

Z29

ICPC

Social problem NOS

4.1

17.4

164

M01AC01

ATC

piroxicam; systemic, rectal

1.6

17.3

544

3650

E970A

ICD-9 Finland

Injury due to legal intervention by firearms

24.1

17.3

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

20.9

17.3

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

8.1

17.2

H02AB04

ATC

methylprednisolone; systemic

1.5

17.2

550

3708

M54.2

ICD-10 Finland

Cervicalgia

1.9

17.1

258

1394

R33

ICD-10 Finland

Retention of urine

1.9

17.1

238

1251

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.0

17.1

108

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.0

646

4522

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

17.0

286

1606

R55

ICD-10 Finland

Syncope and collapse

1.7

17.0

360

2176

3000B

ICD-9 Finland

Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]

31.6

17.0

F50.3

ICD-10 Finland

Atypical bulimia nervosa

31.6

17.0

D10AF01

ATC

clindamycin; topical

2.1

17.0

199

978

N06AD02

ATC

50.2

17.0

D06

ICPC

Abdominal pain localized other

1.8

16.9

285

1601

R1250

NOMESCO Finland

Evaluation of functional capability

3.2

16.9

276

SPAT1263

SPAT

Sampling

1.3

16.9

1598

13149

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

16.9

116

435

R03AC13

ATC

formoterol; inhalant

2.1

16.9

189

912

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

9.0

16.9

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

16.8

284

1599

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

12.1

16.8

E000006

ATC

1.8

16.8

280

1568

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

14.1

16.8

SFA00

NOMESCO Finland

Small filling

1.6

16.7

480

3148

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.6

16.7

410

2585

R03BA08

ATC

ciclesonide; inhalant

1.8

16.7

317

1854

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

35.1

16.6

E87.6

ICD-10 Finland

Hypokalaemia

2.7

16.6

113

423

M01AX01

ATC

nabumetone; oral

2.2

16.6

174

813

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

16.6

954

7243

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

170.5

16.5

Z72.0

ICD-10 Finland

Tobacco use

3.0

16.5

326

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.7

16.5

117

R01AD11

ATC

triamcinolone; nasal

1.7

16.5

348

2104

A11

ICPC

Chest pain NOS

1.8

16.4

274

1537

-60

ICPC

Result test/procedure

1.9

16.4

229

1207

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

16.4

306

1781

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

40.2

16.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.1

16.3

101

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

16.2

383

2390

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

16.1

136

573

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.8

16.1

F06.7

ICD-10 Finland

Mild cognitive disorder

3.2

16.1

276

D07XC01

ATC

betamethasone, combinations; topical

1.6

16.1

438

2837

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

16.0

490

3263

SPAT1262

SPAT

Handing over of treatment supplies

1.5

16.0

647

4584

Z73.0

ICD-10 Finland

Burn-out

2.9

16.0

344

A10BH01

ATC

sitagliptin; oral

1.7

15.9

336

2026

K85

ICPC

Elevated blood pressure

1.5

15.9

550

3770

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

9.5

15.9

E66

ICD-10 Finland

Obesity

2.2

15.9

162

750

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

15.8

186

915

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

15.8

936

7133

L86

ICPC

Back syndrome with radiating pain

2.0

15.8

210

1085

C09AA02

ATC

enalapril; systemic

1.4

15.8

709

5135

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.6

15.8

112

431

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.6

15.8

115

449

P17

ICPC

Tobacco abuse

4.2

15.8

141

SPAT1051

SPAT

Guidance regarding sleep disorders

3.8

15.7

180

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

15.7

217

1137

H02BX01

ATC

methylprednisolone, combinations; systemic

2.0

15.7

204

1044

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

15.7

221

1168

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

15.7

398

2528

L14

ICPC

Leg/thigh symptom/complaint

1.8

15.6

257

1436

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

26.3

15.6

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.8

15.5

177

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

19.2

15.5

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

15.5

373

2337

D01AC03

ATC

econazole; topical

1.9

15.5

237

1289

SBB10

NOMESCO Finland

Teeth copy

2.0

15.4

194

981

SPAT1227

SPAT

Substance abuse rehabilitation

10.8

15.4

K03.00

ICD-10 Finland

Approximal wear

2.0

15.4

187

932

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

15.4

357

J05AB01

ATC

aciclovir; systemic

1.4

15.4

785

5822

K07

ICPC

Swollen ankles/oedema

2.2

15.4

149

674

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

15.3

932

7133

XF402

NOMESCO Finland

ECG with work load test

1.6

15.3

413

2666

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

15.3

306

1817

L09

ICPC

Arm symptom/complaint

2.2

15.2

160

751

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

15.2

227

1225

C01DA14

ATC

isosorbide mononitrate; oral

1.6

15.2

466

3105

K08.80

ICD-10 Finland

Toothache NOS

1.8

15.2

286

1668

C10AA07

ATC

rosuvastatin; oral

1.4

15.2

921

7041

R03BC03

ATC

nedocromil; inhalant

1.8

15.1

282

1637

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.7

15.1

C09CA06

ATC

candesartan; oral

1.4

15.1

807

6034

R00.2

ICD-10 Finland

Palpitations

1.8

15.1

255

1438

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

15.1

299

1770

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.7

15.1

346

2141

C01CA01

ATC

etilefrine; systemic

5.5

15.0

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

15.0

379

2402

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

15.0

636

4551

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

15.0

170

822

N06BA07

ATC

modafinil; oral

13.9

15.0

A13

ICPC

Concern/fear medical treatment

3.6

15.0

188

C10AC01

ATC

colestyramine; oral

2.7

15.0

103

390

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

14.9

433

2846

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

14.9

337

5052

R03AC12

ATC

salmeterol; inhalant

2.2

14.9

158

746

SPAT1284

SPAT

Extensive health certificate

2.8

14.9

355

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

14.9

169

819

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

14.9

316

1913

K04.08

ICD-10 Finland

Other specified pulpit

1.9

14.8

220

1186

RT250

NOMESCO Finland

31.8

14.8

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.7

14.8

340

2105

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

14.8

279

1629

WX110

SPAT

2.1

14.7

173

851

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

14.7

620

4425

F43.2

ICD-10 Finland

Adjustment disorders

3.9

14.7

156

UJH02

NOMESCO Finland

Anoscopy

2.1

14.7

161

771

ADA20

NOMESCO Finland

Thoracal sympathectomy

21.1

14.6

K58

ICD-10 Finland

Irritable bowel syndrome

2.8

14.6

347

R01AX03

ATC

ipratropium bromide; nasal

2.8

14.6

347

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

14.6

115

470

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

14.6

183

925

RS220

NOMESCO Finland

3.9

14.6

152

SPAT1325

SPAT

Vaccination

1.3

14.6

1276

10326

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

+∞

14.6

A91

ICPC

Abnormal result investigation NOS

2.1

14.6

167

814

R13

ICD-10 Finland

Dysphagia

1.9

14.5

212

1136

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

14.5

268

1554

F13.9

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder

150.4

14.5

N06AC01

ATC

150.4

14.5

K04

ICPC

Palpitations/awareness of heart

2.0

14.5

191

987

X58

ICD-10 Finland

Exposure to other specified factors

1.5

14.4

481

3266

L20

ICPC

Joint symptom/complaint NOS

2.3

14.4

131

574

L05

ICPC

Flank/axilla symptom/complaint

1.9

14.4

199

1044

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.0

14.4

190

977

R06.4

ICD-10 Finland

Hyperventilation

3.8

14.4

159

IHZ04

SPAT

15.4

14.4

F43.00

ICD-10 Finland

Acute stress reaction mild

3.0

14.3

274

H81

ICPC

Excessive ear wax

1.5

14.3

570

4023

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.8

14.3

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

14.3

751

5596

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

14.3

127

552

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

14.2

341

2136

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

14.2

108

432

SPAT1237

SPAT

Psychotherapy

10.4

14.2

G04CA01

ATC

alfuzosin; oral

1.6

14.2

367

2342

J20

ICD-10 Finland

Acute bronchitis

1.6

14.2

342

2145

U13

ICPC

Bladder symptom/complaint other

2.6

14.2

105

415

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.0

14.2

175

878

N02CC02

ATC

naratriptan; oral

3.1

14.1

257

M03AX01

ATC

botulinum toxin; parenteral

4.9

14.1

N02CC05

ATC

almotriptan; oral

2.3

14.0

134

603

R03DA04

ATC

theophylline; systemic, rectal

2.1

14.0

165

812

ZXA10

NOMESCO Finland

Bilateral

1.4

14.0

681

5002

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

14.0

120

513

D06BB03

ATC

aciclovir; topical

2.0

13.9

189

987

R5599

NOMESCO Finland

Other rehabilitation service

2.6

13.9

100

389

D01AE15

ATC

terbinafine; topical

1.8

13.9

260

1513

G50.1

ICD-10 Finland

Atypical facial pain

3.2

13.9

222

N05CG01

ATC

30.1

13.9

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

13.8

109

445

K04.0

ICD-10 Finland

Pulpitis

1.7

13.8

322

1998

G03DB02

ATC

megestrol; oral (pregnadien derivatives)

2.0

13.8

175

889

R29

ICPC

Respiratory symptom/complaint other

1.9

13.8

214

1173

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

3.8

13.8

155

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

53.5

13.8

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

13.8

341

2152

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

13.8

285

1710

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

20.1

13.8

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

13.7

444

2995

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.9

13.7

285

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

10.4

13.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

13.7

466

3181

F03

ICD-10 Finland

Unspecified dementia

2.5

13.6

105

424

J01AA04

ATC

lymecycline; systemic

1.5

13.6

467

3194

A60

ICPC

General and Unspecified, Result test/procedure

2.1

13.6

156

763

N06AA03

ATC

imipramine oxide; oral

75.3

13.6

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

13.5

143

673

F33.31

ICD-10 Finland

Recurrent depression, severe episode of somatic syndrome

+∞

13.5

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

+∞

13.5

S10

ICPC

Boil/carbuncle

1.9

13.5

190

1005

M01AG01

ATC

mefenamic acid; oral

2.4

13.5

110

456

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

13.5

409

2715

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

13.5

343

2177

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

13.5

374

2429

N39.3

ICD-10 Finland

Stress incontinence

1.7

13.4

267

1585

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

13.4

583

4183

30188

ICD-8 Finland

Personality disorders, Alia definita

10.0

13.4

IHZ07

SPAT

16.2

13.4

A02BB01

ATC

misoprostol; oral

5.6

13.4

H53.2

ICD-10 Finland

Diplopia

2.4

13.4

112

471

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

25.8

13.3

M01AX05

ATC

glucosamine; oral

1.4

13.3

757

5709

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

13.3

367

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.1

13.3

126

N30

ICD-10 Finland

Cystitis

1.7

13.3

255

1500

A05

ICPC

Feeling ill

2.0

13.2

164

827

X14

ICPC

Vaginal discharge

3.4

13.2

187

G04BD09

ATC

trospium; oral

2.7

13.2

345

R01BA01

ATC

phenylpropanolamine; oral

1.8

13.2

216

1205

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

40.2

13.1

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

40.2

13.1

RT150

NOMESCO Finland

40.2

13.1

R07.0

ICD-10 Finland

Pain in throat

1.9

13.1

200

1087

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

13.1

120

530

R41.3

ICD-10 Finland

Other amnesia

2.6

13.1

365

S02

ICPC

Pruritus

2.3

13.1

116

503

U07

ICPC

Urine symptom/complaint other

1.9

13.1

196

1062

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

8.3

13.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

13.0

187

998

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

28.4

12.9

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.4

12.9

Z03

ICPC

Housing/neighbourhood problem

7.4

12.9

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

12.9

100

406

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

12.9

148

724

N04BB01

ATC

amantadine; oral

3.1

12.9

235

P19

ICPC

Drug abuse

7.7

12.8

N76.0

ICD-10 Finland

Acute vaginitis

2.0

12.8

159

802

D93

ICPC

Irritable bowel syndrome

4.2

12.8

116

F40.2

ICD-10 Finland

Specific (isolated) phobias

6.9

12.8

R07

ICPC

Sneezing/nasal congestion

1.9

12.8

200

1100

F43.0

ICD-10 Finland

Acute stress reaction

2.2

12.8

135

634

R50.9

ICD-10 Finland

Fever, unspecified

1.5

12.8

463

3202

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

5.7

12.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

12.8

161

818

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

12.7

1024

8159

SPAT1360

SPAT

Extensive global examination

1.7

12.7

253

1500

C05AA01

ATC

hydrocortisone; rectal, topical

1.8

12.7

206

1145

N48.4

ICD-10 Finland

Impotence of organic origin

2.9

12.7

254

J01FA09

ATC

clarithromycin; systemic

1.3

12.6

1214

9922

R15

ICD-10 Finland

Faecal incontinence

2.6

12.6

362

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

12.6

161

820

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

15.4

12.6

IGP01

NOMESCO Finland

Psychiatric family contact

15.4

12.6

EB1AA

SPAT

1.9

12.6

176

930

K02.2

ICD-10 Finland

Caries of cementum

2.0

12.6

153

767

F06.32

ICD-10 Finland

Organic depression

70.0

12.6

R12

ICD-10 Finland

Heartburn

1.7

12.6

243

1429

S22.3

ICD-10 Finland

Fracture of rib

1.8

12.6

216

1225

E000002

ATC

1.5

12.5

389

2597

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

12.5

123

559

OAA80

SPAT

0.4

12.5

1072

J01DA08

ATC

[U] cefaclor; oral

1.6

12.5

351

2287

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

12.5

357

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

12.5

325

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

+∞

12.5

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

12.5

229

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

9.3

12.4

N07AB01

ATC

carbachol; systemic

7.3

12.4

F40.0

ICD-10 Finland

Agoraphobia

130.3

12.4

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

20.1

12.4

G01AF01

ATC

metronidazole; vaginal

1.5

12.4

389

2604

XG466

NOMESCO Finland

Sleep oxymetry

2.3

12.4

114

503

C08CA13

ATC

lercanidipine; oral

1.5

12.4

455

3153

SPAT1377

SPAT

Polysomnography

2.2

12.4

127

590

R95

ICPC

Chron obstructive pulmonary disease

2.6

12.4

346

T74.1

ICD-10 Finland

Physical abuse

3.5

12.3

161

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

12.3

434

2986

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.6

12.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

12.2

318

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

12.2

177

950

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.6

12.2

310

1970

D02AE01

ATC

carbamide; topical

1.7

12.1

241

1431

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.4

12.1

168

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

12.1

126

591

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

12.1

419

2867

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

15.9

12.1

S04

ICPC

Lump/swelling localized

1.6

12.1

316

2024

IHZ02

SPAT

12.4

12.1

G04BD01

ATC

emepronium; systemic

4.7

12.1

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

12.1

538

3882

P02

ICPC

Acute stress reaction

2.2

12.1

120

551

A92

ICPC

Allergy/allergic reaction NOS

2.5

12.0

372

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

26.7

12.0

IEV99

NOMESCO Finland

Other psychiatric network intervention

26.7

12.0

F25

ICD-10 Finland

Schizoaffective disorders

18.1

12.0

G03HB01

ATC

cyproterone and estrogen; systemic

1.6

12.0

307

1954

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.3

12.0

100

P50

ICPC

Psychological, Medication/prescr/renewal

11.0

12.0

D02

ICPC

Abdominal pain epigastric

1.8

12.0

198

1107

EB1SA

SPAT

2.1

12.0

137

670

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

12.0

137

670

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.7

12.0

234

1382

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

12.0

248

1492

C03DA01

ATC

spironolactone; oral

1.6

11.9

343

2249

R63.1

ICD-10 Finland

Polydipsia

13.4

11.9

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.3

11.9

109

483

D09

ICPC

Nausea

2.2

11.9

119

548

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

11.9

298

1889

T07

ICPC

Weight gain

4.7

11.9

Z00.8

ICD-10 Finland

Other general examinations

1.7

11.9

237

1410

RF242

NOMESCO Finland

46.8

11.9

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.8

11.9

199

1121

H29

ICPC

Ear symptom/complaint other

1.5

11.8

359

2386

N29

ICPC

Neurological sympt/complt other

2.9

11.8

243

R05DB05

ATC

pentoxyverine; oral, rectal

2.1

11.8

136

668

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

7.0

11.8

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

14.7

11.8

M01AH03

ATC

valdecoxib; oral

1.7

11.8

234

1392

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

244

181

14.09

263.02

3.3

2.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

137

24.22

192.29

11.7

15.9

0.6

0.7

mmol/l

0.45

117

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

999

3992

2.85

172.47

2.1

1.5

1.4

5.42

857

3550

(3009466) Valproate [Moles/volume] in Serum or Plasma

215

266

8.38

162.17

5.6

4.9

366.2

369.1

umol/l

0.08

183

235

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2528

15754

2.16

158.66

2.2

1.9

97.6

96.2

pmol/l

0.72

1272

8061

(3011288) Drugs identified in Urine by Screen method

274

471

6.08

152.80

4.6

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4137

31884

2.38

144.21

5.0

3.8

14.5

14.9

pmol/l

16.67

3780

29074

(3015377) Calcium [Moles/volume] in Serum or Plasma

2177

13227

2.10

141.35

3.2

3.6

2.4

mmol/l

0.01

1889

11526

(3019309) Folate [Moles/volume] in Red Blood Cells

1290

6376

2.35

140.17

1.8

1.7

1216.6

1168.6

nmol/l

0.93

951

4835

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2639

17949

1.94

117.74

5.9

6.0

1.2

mmol/l

0.05

2402

16279

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2468

16416

1.95

117.68

3.2

2.7

102.1

136.2

ug/l

16.58

2257

15343

(1001926) Buprenorphine [Presence] in Urine by Screen method

282

637

4.62

115.30

3.2

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4061

32268

2.12

112.41

7.9

7.5

77.6

77.7

u/l

0.04

3817

30465

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2826

19881

1.91

111.56

6.1

6.8

1.2

mmol/l

0.00

2374

16821

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1297

6977

2.14

111.17

2.9

3.2

2.4

2.5

mmol/l

1.63

1106

6127

(3021960) Folate [Moles/volume] in Serum or Plasma

1501

8530

2.06

111.14

1.6

1.5

21.2

20.6

nmol/l

0.76

1277

7255

(3024561) Albumin [Mass/volume] in Serum or Plasma

2528

17245

1.89

108.81

4.3

5.0

36.0

35.6

g/l

3.19

2323

16055

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2439

16663

1.86

102.43

2.5

2.2

78.3

78.1

nmol/l

0.12

2178

15044

(3018418) pH of Serum or Plasma

1857

11683

1.91

100.47

4.0

4.3

7.4

0.34

323

2246

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4587

38877

2.37

98.41

6.3

4.4

1.8

2.1

mu/l

3.67

4270

35582

(3016879) Cocaine [Presence] in Urine

300

811

3.86

96.42

3.2

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

16.91

96.17

1.5

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1534

9187

1.94

95.29

2.4

2.2

2.8

3.0

mg/l

1.51

1301

7936

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1842

11909

1.84

88.97

2.3

2.0

205.7

201.6

u/l

0.07

1705

11155

(3027008) Opiates [Presence] in Urine

307

926

3.46

83.68

3.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

305

918

3.46

83.40

3.3

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3408

26675

1.78

83.39

5.3

4.0

160.2

1295.6

e6/l

2.76

343

(3028300) Cannabinoids [Presence] in Urine

307

929

3.45

83.25

3.3

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2855

21287

1.74

82.47

5.9

6.3

10.1

11.5

umol/l

9.48

2684

20277

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1396

8460

1.88

81.49

1.3

1.2

1.3

1.8

u/ml

1.03

357

2282

(3013650) Neutrophils [#/volume] in Blood by Automated count

3121

23911

1.75

81.33

10.0

9.1

4.1

4.0

e9/l

1.83

2667

20870

(3013707) Erythrocyte sedimentation rate by Westergren method

3817

31081

1.82

79.62

4.3

4.0

12.1

12.2

mm/h

0.22

3543

28907

(3036481) Cortisol [Moles/volume] in Serum or Plasma

682

3203

2.30

79.51

2.2

2.4

351.6

379.3

nmol/l

3.35

628

2965

(3027944) Amphetamines [Presence] in Urine

294

923

3.31

75.10

3.1

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1936

13209

1.74

74.62

3.4

3.2

38.7

35.2

u/l

0.17

1810

12561

(3019198) Lymphocytes [#/volume] in Blood

2787

21039

1.69

73.36

6.2

5.9

2.0

1.9

e9/l

0.40

2399

18539

(3013115) Eosinophils [#/volume] in Blood

2807

21238

1.69

73.19

6.6

6.0

0.2

e9/l

0.38

2407

18659

(3001604) Monocytes [#/volume] in Blood

2722

20442

1.68

72.89

6.1

5.8

0.6

e9/l

0.54

2276

17675

(3006315) Basophils [#/volume] in Blood

2731

20529

1.68

72.85

6.1

5.8

0.0

e9/l

0.61

2281

17746

(3018095) Leukocytes [#/volume] in Urine

2033

14128

1.71

72.84

4.1

3.5

90.6

100.9

e6/l

0.12

1409

9888

(3015736) pH of Urine

2142

15213

1.69

69.98

3.8

3.2

—

5.8

—

(3044889) 12 lead EKG panel

3663

30006

1.72

68.58

4.3

3.6

—

(36304419) Bacteria [Presence] in Urine

1612

10672

1.73

67.75

3.5

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1225

7519

1.82

66.62

1.5

2.4

g/l

0.46

680

4661

(3033658) Prothrombin time (PT) actual/Normal

1585

10551

1.72

64.72

4.3

3.8

92.6

90.5

2.74

1546

10319

(3030467) Casts [#/volume] in Urine by Automated count

1633

10975

1.71

64.29

3.6

3.0

0.4

e6/l

0.08

1232

8158

(40758558) Short blood count panel - Blood

1556

10340

1.72

63.75

7.8

6.9

—

(3048689) Calprotectin [Mass/mass] in Stool

837

4624

1.96

62.73

2.2

2.3

113.3

144.5

ug/g

1.69

641

3711

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1786

12369

1.67

62.36

2.7

2.4

58.2

58.7

u/l

0.11

1624

11485

(3037467) Urinalysis macro (dipstick) panel - Urine

3468

28352

1.65

61.67

4.9

4.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3429

27956

1.65

61.62

3.9

2.8

53.4

46.2

u/l

3.19

3157

26160

(3013826) Glucose [Moles/volume] in Serum or Plasma

3022

23979

1.61

59.76

5.0

4.4

6.6

6.7

mmol/l

1.27

2829

22371

(3009508) Creatinine [Moles/volume] in Urine

1811

12693

1.65

59.75

3.4

3.2

7.5

mmol/l

0.20

1501

10705

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

566

2774

2.17

58.55

2.1

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

1721

11998

1.64

57.49

3.6

3.0

39.1

88.8

e6/l

1.97

1314

9103

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1255

8057

1.73

57.23

1.8

1.6

45754699.2

38499396.6

pmol/l

0.13

1001

6782

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

684

3649

2.00

56.26

2.5

2.3

38.2

37.2

u/l

0.08

574

3152

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

603

3114

2.06

54.17

2.2

1.8

—

(3022096) Basophils/100 leukocytes in Blood

2432

18670

1.56

52.79

6.2

6.1

0.7

0.49

2233

17457

(3000850) Epithelial cells [#/volume] in Urine

1243

8134

1.69

52.12

2.8

2.5

5.6

5.4

e6/l

0.23

1089

7119

(44816559) Phosphatidylethanol [Mass/volume] in Blood

181

526

3.53

52.11

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

2498

19346

1.55

51.77

6.3

8.6

8.7

0.34

2304

18172

(3006504) Eosinophils/100 leukocytes in Blood

2487

19248

1.55

51.65

6.1

2.9

0.18

2292

17978

(3021589) Normoblasts [#/volume] in Blood

2398

18416

1.55

51.52

10.0

9.3

0.0

e9/l

0.05

1887

15134

(4198724)

9.62

51.26

3.4

1.5

—

(3026782) Osmolality of Urine

1160

7490

1.70

50.97

3.0

2.7

521.6

551.6

mosm/kgh2o

4.46

974

6394

(3002030) Lymphocytes/100 leukocytes in Blood

2550

19888

1.55

50.86

6.2

6.1

28.2

28.1

0.27

2343

18563

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

20.14

49.47

2.3

2.7

17.6

19.1

umol/l

0.22

(40768797) Stomach Pathology biopsy report

909

5551

1.77

48.49

1.3

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

2509

19632

1.53

48.39

6.0

5.9

57.0

57.1

0.24

2315

18407

(3011397) Hemoglobin [Presence] in Urine by Test strip

1373

9396

1.62

47.65

4.0

3.4

—

(42870588) Differential panel, method unspecified - Blood

1868

13789

1.55

46.58

5.8

6.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

2552

20190

1.51

45.75

5.4

4.6

0.0

estimate

0.00

496

3623

(3026008) Bacteria identified in Urine by Culture

1617

11598

1.57

45.62

3.6

2.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

516

2674

2.03

45.57

2.7

2.0

12.6

12.8

nmol/l

0.19

449

2383

(3019550) Sodium [Moles/volume] in Serum or Plasma

4839

44516

2.04

45.13

19.6

14.5

139.5

139.8

mmol/l

11.26

4741

43429

(3035350) Ketones [Presence] in Urine by Test strip

2532

20062

1.50

44.65

4.2

3.4

0.0

estimate

1.08

481

3569

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

471

2406

2.05

43.20

2.9

3.6

4.4

4.5

pmol/l

1.08

400

2169

(3009261) Glucose [Presence] in Urine by Test strip

2560

20422

1.49

43.08

4.2

3.4

0.0

estimate

0.25

480

3536

(1002224) Polysomnography panel

344

1572

2.27

41.89

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4425

39830

1.69

41.43

6.8

5.4

39.7

39.6

mmol/mol

0.33

4109

36977

(3023103) Potassium [Moles/volume] in Serum or Plasma

4836

44692

1.98

41.22

19.6

14.6

4.0

mmol/l

2.38

4726

43504

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

8.49

41.18

2.2

2.7

122.9

151.0

nmol/l

1.07

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4699

43034

1.84

41.12

16.5

12.7

22.7

23.7

mg/l

1.22

3760

33469

(3012095) Magnesium [Moles/volume] in Serum or Plasma

982

6405

1.66

40.38

2.9

3.4

0.8

mmol/l

0.60

903

5999

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1020

6737

1.64

39.85

3.0

2.6

1.1

1.2

e6/l

0.14

560

3804

(3014111) Lactate [Moles/volume] in Serum or Plasma

574

3251

1.86

38.70

7.0

7.2

1.3

mmol/l

0.04

549

3149

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1532

11184

1.52

38.52

3.1

2.9

926.4

1377.5

ng/l

6.41

1267

9658

(3022948) Iron [Moles/volume] in Serum or Plasma

908

5923

1.64

36.99

2.3

2.6

12.9

13.1

umol/l

0.33

828

5554

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

952

6286

1.63

36.93

3.1

2.8

3.3

2.7

e6/l

0.85

491

3372

(3004789) Transferrin [Mass/volume] in Serum or Plasma

845

5456

1.65

35.73

2.3

2.6

2.4

2.3

g/l

2.04

749

5111

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

345

1683

2.12

35.63

3.8

4.3

24.3

24.1

mmol/l

0.50

315

1526

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

240

1016

2.43

34.78

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1948

15174

1.45

34.46

3.9

3.2

30.7

45.2

ng/l

2.25

1279

10115

(3000991) Gas panel - Venous blood

539

3102

1.82

34.34

8.0

8.6

—

(4010399)

496

2792

1.86

33.93

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

240

1032

2.39

33.59

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

239

1026

2.39

33.57

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1617

12218

1.47

33.28

3.3

255.7

416.0

mg/l

0.88

1004

7529

(3003327) Ova and parasites identified in Stool by Light microscopy

264

1194

2.27

32.88

1.6

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1527

11441

1.47

32.70

1.6

1.5

1.3

mmol/l

8.50

1234

9633

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4589

42267

1.66

32.59

5.5

4.3

6.0

5.9

mmol/l

6.69

4205

38765

(3021387) Prolactin [Units/volume] in Serum or Plasma

231

990

2.39

32.57

1.7

339.9

295.9

mu/l

1.12

209

910

(3022145) Colonoscopy Study observation

732

4657

1.66

32.55

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1024

7078

1.55

32.21

1.3

66.5

35.9

iu/ml

0.38

265

2310

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1104

7762

1.53

32.13

3.8

3.5

147.0

620.7

ng/l

3.32

821

6025

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4487

41134

1.61

32.08

15.5

12.1

82.1

80.8

ml/min/173m2

3.65

3750

33909

(3003458) Phosphate [Moles/volume] in Serum or Plasma

772

5001

1.64

31.93

4.4

6.3

1.0

mmol/l

0.51

702

4694

(3019150) Specific gravity of Urine by Refractometry

1189

8513

1.51

31.72

4.6

3.7

1.0

kg/l

0.18

148

1294

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

173

655

2.70

31.61

2.1

1.8

204.9

207.4

pmol/l

0.10

161

625

(3023368) Bacteria identified in Blood by Culture

1388

10300

1.47

30.89

4.5

4.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

222

959

2.37

30.75

2.0

1.7

40.5

42.5

nmol/l

0.62

216

929

(3020682) Albumin/Creatinine [Ratio] in Urine

1670

12860

1.44

30.47

4.1

4.0

8.1

8.9

mg/mmol

0.27

996

7994

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

718

4620

1.64

30.40

2.5

2.8

7.2

8.4

umol/l

0.92

596

4065

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1224

8893

1.49

30.19

1.9

1.7

1.0

1.2

mg/l

1.78

917

6866

(3029937) Albumin [Presence] in Urine by Test strip

1416

10620

1.46

29.59

4.9

3.8

0.0

estimate

1.79

481

3498

(3025941) Bacteria identified in Stool by Culture

380

2064

1.91

28.93

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

771

5117

1.59

28.63

2.4

2.7

21.9

22.9

1.16

665

4412

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

455

2638

1.79

28.10

1.5

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

229

1044

2.25

27.99

1.4

291.1

269.6

ug/g

0.28

129

609

(3002385) Erythrocyte distribution width [Ratio]

3973

35824

1.44

27.53

20.7

15.7

13.7

1.37

3884

35072

(36660697) Celiac disease serology panel - Serum

500

3019

1.72

26.77

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

727

4867

1.57

25.82

7.7

7.1

104.1

104.6

mmol/l

1.96

714

4776

(3032080) INR in Blood by Coagulation assay

2011

16342

1.37

25.62

8.1

8.8

1.2

inr

1.56

596

4601

(3037522) Nuclear Ab [Titer] in Serum

801

5513

1.53

25.08

1.4

1.3

489.9

576.0

titre

0.60

145

1199

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

102

329

3.14

24.97

1.6

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

632

4126

1.60

24.93

1.9

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

863

6046

1.51

24.84

1.9

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

944

6737

1.49

24.83

1.3

1.2

6.3

13.5

u/ml

4.21

328

2716

(3000494) Fungus identified in Specimen by Culture

716

4823

1.56

24.68

1.5

1.4

—

(3002032) Base excess in Venous blood by calculation

529

3337

1.65

23.94

3.8

2.1

1.9

mmol/l

0.59

460

2737

(3024354) Oxygen [Partial pressure] in Venous blood

447

2700

1.72

23.83

3.6

3.1

4.6

4.5

kpa

0.46

434

2619

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

625

4118

1.59

23.65

1.9

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

860

6088

1.49

23.41

1.9

1.7

—

(40761535) Cells panel - Urine sediment

505

3169

1.66

23.30

3.9

3.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

528

3353

1.64

23.24

3.8

5.9

5.8

kpa

2.29

519

3261

(3009214) Lutropin [Units/volume] in Serum or Plasma

190

875

2.22

22.69

1.4

1.3

8.7

11.8

u/l

2.59

150

720

(3052851) Hemolysis interference index of Serum or Plasma

231

1148

2.06

22.67

2.6

3.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

337

1903

1.82

22.64

1.1

1.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

653

4388

1.56

22.63

7.2

7.4

5.2

5.1

kpa

5.24

631

4178

(3003396) Base excess in Arterial blood by calculation

652

4382

1.56

22.58

7.1

7.4

1.2

1.0

mmol/l

0.72

558

3394

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

565

3677

1.60

22.48

2.3

2.2

0.2

g/l

0.75

519

3459

(3027801) Oxygen [Partial pressure] in Arterial blood

652

4388

1.55

22.43

7.2

7.4

11.5

12.8

kpa

11.01

628

4173

(3018677) aPTT in Platelet poor plasma by Coagulation assay

870

6223

1.48

22.40

2.0

2.1

29.7

29.8

0.16

848

6053

(3007853) Bacteria identified in Skin by Aerobe culture

657

4439

1.55

22.20

1.9

1.7

—

(3042936) Bacteria identified in Isolate by Culture

796

5608

1.49

22.08

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

304

1684

1.85

21.72

2.4

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

331

2.97

21.60

1.4

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

156

675

2.35

21.60

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

156

675

2.35

21.60

1.4

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.93

21.29

2.2

2.4

138.1

156.0

umol/l

0.10

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

251

1315

1.95

21.25

2.3

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

636

4314

1.54

21.05

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1178

9052

1.39

20.17

4.6

4.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4886

46603

1.65

19.94

12.5

9.9

26.6

26.2

u/l

0.93

4737

45013

(3014007) Fractional oxyhemoglobin in Arterial blood

396

2435

1.68

19.69

9.3

92.6

94.3

3.80

396

2428

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

502

3299

1.58

19.05

2.5

2.2

5.6

8.2

ug/l

3.58

423

2959

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

709

5019

1.48

19.01

8.2

6.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

390

2411

1.67

18.99

9.3

0.7

0.25

390

2390

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

390

2420

1.66

18.71

9.3

9.2

1.4

1.3

1.30

390

2402

(3023323) Follitropin [Units/volume] in Serum or Plasma

290

1663

1.79

18.51

1.4

1.3

26.5

33.8

iu/l

3.45

242

1456

(3016502) Oxygen saturation in Arterial blood

574

3915

1.52

18.41

7.5

7.9

94.7

96.0

3.36

562

3746

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

175

849

2.10

18.36

1.2

1.3

418.8

547.9

mg/l

7.14

168

814

(3013139) Helicobacter pylori Ag [Presence] in Stool

431

2763

1.61

18.15

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1866

15559

1.31

18.11

4.5

3.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

607

4204

1.50

18.09

2.1

2.6

1.8

0.74

524

3764

(3026493) Urate [Moles/volume] in Serum or Plasma

1389

11116

1.34

18.01

2.5

2.6

4784.3

5022.9

umol/l

0.07

1160

9729

(40768804) Tissue Pathology biopsy report

2099

17805

1.30

17.83

2.2

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2978

26460

1.29

17.48

3.1

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

268

1540

1.78

16.99

1.2

1.3

0.2

1.2

u/ml

2.67

154

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4860

46511

1.57

16.94

19.4

15.0

76.0

76.5

umol/l

0.53

4860

46492

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

339

2093

1.66

16.58

3.3

3.4

1.8

1.9

mmol/l

0.21

253

1540

(3003181) Sodium [Moles/volume] in Urine

129

578

2.26

16.55

1.4

1.3

58.3

65.3

mmol/l

1.09

472

(3002173) Hemoglobin [Mass/volume] in Arterial blood

531

3655

1.50

16.24

7.9

8.3

121.8

121.0

g/l

0.41

522

3513

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

353

2216

1.64

16.17

3.4

5.2

5.1

kpa

1.38

330

2049

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

153

746

2.08

15.89

1.2

1.3

13.1

28.7

e6/l

0.98

115

576

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

153

746

2.08

15.89

1.2

1.4

1016.9

1000.4

e6/l

0.01

121

610

(3023183) Ammonium ion [Moles/volume] in Plasma

143

683

2.12

15.68

2.7

2.8

40.5

33.6

umol/l

0.55

126

589

(3022217) INR in Platelet poor plasma by Coagulation assay

704

5150

1.42

15.67

22.2

24.3

1.2

1.3

inr

1.84

767

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

216

1192

1.85

15.66

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

15.63

1.5

0.0

554.4

—

nmol/l

—

(3009343) pH of Capillary blood

346

2182

1.63

15.56

3.4

7.4

0.32

276

(40761511) CBC panel - Blood by Automated count

4746

45327

1.47

15.27

15.2

11.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

9.50

15.21

9.3

13.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

222

1252

1.81

15.01

2.0

2.3

560.0

714.7

ug/l

0.29

207

1176

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

448

3030

1.52

14.86

3.4

4.0

85.3

92.7

ng/l

1.03

372

2606

(3004716) Salmonella sp identified in Stool by Organism specific culture

303

1883

1.65

14.45

1.2

1.4

—

(3019060) Gas panel - Arterial blood

377

2472

1.57

14.39

4.8

5.1

—

(3020891) Body temperature

247

1468

1.72

13.95

6.6

4.6

—

(3023410) Appearance of Cerebral spinal fluid

343

2.50

13.85

1.3

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

374

2.43

13.77

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

418

2836

1.51

13.65

2.3

2.4

27.4

23.1

au/ml

0.19

177

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

148

755

1.99

13.63

1.1

1.2

3.8

mmol/l

0.06

141

709

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

323

2070

1.60

13.60

1.6

1.4

—

(3024928) Oxygen saturation in Venous blood

150

772

1.97

13.48

3.9

3.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

200

2.97

13.44

1.1

1.0

333.2

358.7

ng/l

0.23

149

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

200

2.97

13.44

1.1

1.0

804.9

727.4

ng/l

0.49

144

(3044640) Blood type and Crossmatch panel - Blood

1574

13240

1.27

13.23

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

890

6946

1.34

13.14

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

203

2.93

13.10

1.1

1.0

39.0

45.6

ng/l

0.50

149

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

384

2594

1.52

12.80

1.2

96.5

153.9

iu/ml

2.41

112

1018

(3043409) Potassium [Moles/volume] in Arterial blood

195

1111

1.78

12.79

5.9

4.3

3.8

3.9

mmol/l

1.09

190

1040

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

267

1660

1.64

12.73

4.1

2.7

0.6

0.11

260

1593

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

335

2203

1.56

12.63

1.7

1.6

—

(3008295) Osmolality of Serum or Plasma

318

2.47

12.47

1.6

1.3

280.6

278.0

mosm/kgh2o

0.38

254

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4655

44560

1.38

12.36

5.6

4.8

2.7

2.8

mmol/l

14.96

4275

41265

(3044290) Cell count panel - Cerebral spinal fluid

138

712

1.96

12.34

1.2

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

311

2027

1.57

12.20

9.0

9.5

24.5

24.3

mmol/l

0.36

285

1913

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

460

3267

1.45

11.93

4.1

3.8

1.2

mmol/l

0.05

386

2907

(3005322) IgE [Units/volume] in Serum or Plasma

356

2404

1.52

11.89

1.3

186.2

233.8

u/ml

0.64

320

2229

(21494755) Public health laboratory ask at order entry panel

295

4431

0.65

11.85

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

216

2.75

11.73

1.5

1.2

1.6

1.2

promille

1.20

173

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

179

1023

1.78

11.65

1.8

2.4

0.0

g/l

0.00

160

957

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

694

5311

1.35

11.58

1.6

—

(1616796) Gas panel - Central venous blood

151

823

1.86

11.48

4.5

3.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

180

1039

1.76

11.33

1.8

2.4

0.0

g/l

0.00

160

960

(3020779) Urea [Moles/volume] in Serum or Plasma

480

3471

1.42

11.28

5.9

8.0

8.9

9.9

mmol/l

2.51

452

3328

(3023520) Reticulocytes [#/volume] in Blood

439

3124

1.44

11.26

2.3

2.8

74.3

69.2

e9/l

1.52

327

2383

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1216

10076

1.27

11.26

2.2

2.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

374

2586

1.48

11.14

1.3

59.8

52.1

au/ml

0.25

127

(3021879) Hepatitis B virus core Ab [Presence] in Serum

414

2921

1.45

11.11

1.4

—

(3011985) Renin [Units/volume] in Plasma

110

554

2.01

10.60

1.5

1.4

64.2

60.7

mu/l

0.06

501

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1125

1.70

10.43

1.8

2.3

0.0

g/l

0.85

168

1042

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

308

2077

1.51

10.37

2.2

2.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

542

4084

1.36

9.95

3.9

3.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

4181

39696

1.26

9.92

19.4

13.7

40.0

39.9

0.38

2971

29144

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4400

42038

1.28

9.85

4.4

3.8

1.4

1.3

mmol/l

25.35

3982

38685

(3015235) Bicarbonate [Moles/volume] in Capillary blood

155

896

1.75

9.76

3.1

3.0

25.0

24.8

mmol/l

0.16

139

772

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

800

1.80

9.76

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

6.83

9.72

1.0

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.83

9.72

1.0

1.1

—

mmol/l

—

(3005719) IgG [Mass/volume] in Serum or Plasma

425

3090

1.41

9.68

2.3

2.8

10.6

10.7

g/l

0.17

373

2843

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

105

538

1.97

9.67

1.4

1.3

25.5

31.7

u/l

1.04

436

(40761536) Microorganisms panel - Urine sediment

453

3332

1.39

9.64

4.8

3.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4563

43834

1.30

9.54

5.0

4.3

4.6

4.7

mmol/l

17.71

4192

40811

(3007566) Smooth muscle Ab [Titer] in Serum

183

1115

1.66

9.52

1.3

83.8

170.0

titre

0.89

103

(3049717) Cytology report of Urine Cyto stain

224

1435

1.59

9.52

2.5

2.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

377

2693

1.43

9.48

1.9

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

483

2.01

9.32

1.3

1.5

—

(3000492) Spirometry study

528

4004

1.35

9.29

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.02

9.28

1.0

1.5

—

38.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

102

527

1.95

9.19

1.4

1.3

390.7

273.2

pmol/l

0.93

409

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

221

2.50

9.17

1.6

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4532

43576

1.28

8.84

4.9

4.3

1.4

1.5

mmol/l

22.07

4143

40388

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

113

3.11

8.77

2.0

2.8

26.6

29.8

umol/l

0.77

(3020630) Protein [Mass/volume] in Serum or Plasma

442

3289

1.38

8.77

2.0

2.8

66.4

66.6

g/l

0.18

389

3007

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

201

1281

1.59

8.76

2.0

2.5

0.6

1.0

g/l

0.98

172

1110

(3023511) Choriogonadotropin [Units/volume] in Urine

440

2.02

8.72

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

186

1165

1.62

8.71

1.8

2.3

38.2

37.6

g/l

0.60

165

1004

(3028626) Oxygen [Partial pressure] in Capillary blood

133

764

1.76

8.61

3.1

2.8

8.1

8.2

kpa

0.32

125

703

(3006184) Hemoglobin [Mass/volume] in Capillary blood

144

847

1.72

8.58

2.6

2.1

130.4

129.1

g/l

0.25

100

597

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

605

1.85

8.54

1.9

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

452

3392

1.36

8.50

2.7

2.5

67.3

66.0

ml/min/173m2

0.29

200

1293

(3008152) Bicarbonate [Moles/volume] in Arterial blood

333

2374

1.43

8.48

8.1

7.2

25.4

24.5

mmol/l

6.01

321

2191

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

230

2.41

8.45

1.1

1.2

13.1

nmol/l

—

(3021901) Oxygen saturation in Capillary blood

117

651

1.82

8.44

3.1

2.7

—

(3002256) Pathology report gross observation

713

5720

1.28

8.37

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

141

832

1.71

8.32

1.2

1.3

24.4

47.9

u/ml

1.25

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

207

1352

1.55

8.14

3.5

3.7

24.9

mmol/l

0.08

192

1239

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

317

2.16

8.13

1.2

55.5

191.0

titre

2.34

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

300

4169

0.70

7.99

1.7

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

333

2401

1.41

7.98

1.7

1.8

1.1

1.4

g/l

3.46

292

2200

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

115

2.97

7.91

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

583

4591

1.30

7.88

1.6

—

(3010421) pH of Blood

157

970

1.64

7.81

4.5

3.9

7.4

1.99

131

831

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

119

683

1.76

7.77

1.3

—

(3022313) Gas panel - Capillary blood

233

1578

1.50

7.76

3.3

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

156

971

1.63

7.55

1.5

1.6

15063.1

11897.5

e6/l

0.24

105

703

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

178

1145

1.57

7.51

1.3

10.5

45.9

u/ml

3.38

(3035320) C reactive protein [Mass/volume] in Body fluid

269

2.21

7.48

3.3

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

221

1493

1.50

7.46

1.6

1.7

—

(3025130) Human papilloma virus identified in Specimen

517

1.85

7.40

1.5

1.7

—

(3007463) Buprenorphine [Presence] in Urine

+∞

7.29

16.7

0.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

211

1421

1.51

7.24

2.0

2.5

2.9

3.1

g/l

1.96

172

1109

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

162

1029

1.59

7.23

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

851

0.40

7.21

1.5

1.6

—

(1761868) Lipid panel - Serum or Plasma

1427

16165

0.84

7.17

3.0

2.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

494

1.86

7.16

1.3

1.4

0.4

nmol/l

0.06

379

(3013512) EKG study

1384

12105

1.19

7.11

3.8

3.7

—

(40767503) Oxygen content in Capillary blood by calculation

131

794

1.67

7.06

3.3

2.4

16.5

16.3

0.24

400

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

210

1423

1.50

7.01

1.8

1.7

2.9

3.9

mg/l

0.97

169

948

(3024891) Influenza virus A+B Ag [Presence] in Specimen

153

967

1.60

6.98

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

204

1376

1.50

6.96

1.6

229.3

339.1

titre

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.37

6.95

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.44

6.83

1.2

1.1

—

(3012501) Base excess in Blood by calculation

135

839

1.63

6.62

4.8

3.8

3.0

2.5

mmol/l

0.77

581

(3016038) Potassium [Moles/volume] in Urine

212

2.28

6.61

1.1

31.7

34.8

mmol/l

0.46

183

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

105

611

1.73

6.60

1.4

1.3

0.6

2.5

nmol/l

0.49

100

591

(3026389) Candida sp identified in Specimen by Organism specific culture

515

1.80

6.60

1.4

—

(3021788) Differential panel - Synovial fluid

121

732

1.67

6.59

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1411

1.48

6.54

1.9

2.5

10.2

10.3

g/l

0.18

176

1190

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

613

1.73

6.52

1.4

1.3

0.1

0.3

nmol/l

—

(3006653) Thiamine [Moles/volume] in Blood

158

2.48

6.50

1.2

149.9

133.3

nmol/l

0.83

158

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

565

4542

1.27

6.49

3.9

4.8

235.3

244.6

u/l

0.85

536

4323

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.56

6.45

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

262

2.11

6.31

1.2

29.3

19.0

u/l

0.46

224

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

337

1.97

6.28

1.3

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

460

1.82

6.17

1.2

58.2

62.4

u/l

0.23

309

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

551

1.74

6.07

1.4

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1518

1.44

6.03

1.9

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1519

1.44

6.01

1.9

2.4

7.2

7.4

g/l

1.34

176

1128

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2166

19851

1.15

5.97

3.8

3.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

817

6904

1.22

5.96

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

243

1749

1.41

5.95

2.0

1.9

38.7

39.5

u/l

0.25

211

1544

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

269

2.06

5.92

1.2

91.0

84.2

u/l

0.30

237

(3016650) Hepatitis A virus Ab [Presence] in Serum

103

616

1.69

5.90

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

101

2.78

5.88

1.3

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.53

5.87

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

447

1.80

5.82

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

1518

1.43

5.70

1.9

2.4

4.0

3.8

g/l

0.76

170

1079

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

571

1.69

5.63

1.1

—

(3044941) Cell count panel - Synovial fluid

103

626

1.66

5.58

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

417

3290

1.29

5.57

2.5

2.8

150.9

181.4

ng/l

1.00

380

2995

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.29

5.57

1.3

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

178

1229

1.46

5.49

1.7

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

3.14

5.46

2.0

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.13

5.35

2.1

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.79

5.29

1.2

1.3

83.1

120.2

nmol/l

0.95

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

536

1.69

5.28

1.5

1.3

—

nmol/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

182

2.21

5.21

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1234

10937

1.17

5.18

3.7

3.1

—

(3007461) Platelets [#/volume] in Blood

4964

48744

1.31

5.03

26.1

18.6

254.2

251.7

e9/l

1.93

4846

47477

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

156

1071

1.47

4.99

1.3

5.1

6.6

u/ml

0.26

152

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

176

1238

1.44

4.96

1.5

1.6

1.2

g/l

0.30

171

1171

(3035941) MCH [Entitic mass]

4966

48778

1.30

4.93

25.9

18.5

30.4

30.3

2.37

4898

48109

(3024731) MCV [Entitic volume]

4966

48780

1.30

4.91

25.9

18.6

91.3

91.0

4.31

4899

48114

(3010813) Leukocytes [#/volume] in Blood

4967

48796

1.30

4.87

26.1

18.6

6.7

6.6

e9/l

3.28

4835

47383

(3026361) Erythrocytes [#/volume] in Blood

4966

48787

1.30

4.85

26.0

18.6

4.5

e12/l

8.42

4827

47392

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

674

1.58

4.84

1.4

1.6

0.7

0.8

g/l

0.53

505

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.79

4.81

2.1

1.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.58

4.76

1.1

—

0.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

150

1033

1.47

4.74

1.1

1.0

8.7

u/ml

2.45

115

(4094501)

167

1174

1.44

4.74

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

153

1058

1.46

4.74

1.3

12.5

5.7

u/ml

0.25

100

(3000963) Hemoglobin [Mass/volume] in Blood

4966

48800

1.30

4.73

26.2

18.7

134.8

135.9

g/l

6.49

4901

48134

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

738

1.54

4.61

1.5

1.6

—

(4062490)

406

1.73

4.57

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

341

1.80

4.52

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

144

996

1.46

4.47

1.6

1.9

4.5

4.9

iu/l

0.21

374

(3017569) Oxygen content in Arterial blood

162

2.17

4.42

1.8

—

(3023419) Bacteria identified in Sputum by Culture

464

1.67

4.39

2.4

2.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

870

1.48

4.35

1.2

1.3

2.7

3.8

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

637

1.56

4.34

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

331

1.79

4.33

1.2

1.1

—

19.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.66

4.31

1.1

1.0

0.1

2.2

u/ml

1.07

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

332

1.79

4.29

1.3

1.7

1.4

nmol/l

0.74

293

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

11.68

4.27

1.0

1.2

17.5

8.3

nmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

339

2706

1.27

4.19

1.9

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

127

2.29

4.19

1.4

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

150

1061

1.43

4.16

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

358

1.74

4.15

3.3

3.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

137

957

1.44

4.08

2.6

2.4

182.5

99.7

ug/min

0.49

578

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

2.01

4.06

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

175

2.06

4.04

1.2

1.7

2.2

4.2

nmol/l

0.70

147

(40768443) Skin Pathology biopsy report

246

1894

1.31

4.02

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

516

1.60

3.98

1.2

1.3

81.7

58.4

u/ml

—

(3025159) Blasts/100 leukocytes in Blood

385

3140

1.24

3.97

4.1

4.3

0.1

0.5

1.41

777

(3021440) Promyelocytes/100 leukocytes in Blood

406

3335

1.24

3.92

4.1

4.3

0.1

0.2

0.42

924

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.64

3.92

1.0

1.2

0.2

0.5

nmol/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

178

2.03

3.88

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

762

1.48

3.84

2.6

3.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

230

1.88

3.72

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

420

3492

1.22

3.63

4.1

4.2

0.9

0.19

104

993

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

154

1124

1.38

3.62

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

359

1.68

3.58

1.1

—

(3003338) MCHC [Mass/volume]

3861

37343

1.13

3.58

23.6

16.1

332.4

332.3

g/l

0.17

3830

37097

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

176

1316

1.35

3.56

4.0

3.1

0.4

0.3

u/ml

0.61

745

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.30

3.50

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.89

3.46

1.4

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

150

1100

1.37

3.44

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

382

3167

1.22

3.41

4.0

4.1

0.7

0.6

0.14

719

(3047007) Chlamydophila sp Ab [Presence] in Serum

570

1.52

3.39

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

271

2165

1.27

3.38

9.3

10.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

221

1724

1.29

3.34

1.5

1.8

1.6

g/l

0.08

186

1480

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

321

1.69

3.33

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

158

1178

1.35

3.28

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

114

805

1.43

3.27

2.9

3.9

57.9

57.5

0.14

114

805

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

361

1.64

3.27

1.3

1.5

36.8

31.6

0.40

224

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

256

1.76

3.24

1.0

1.1

2.9

11.4

iu/ml

3.80

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

124

892

1.40

3.22

1.5

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.34

3.19

1.1

1.0

—

(4034850)

180

1376

1.32

3.17

12.0

8.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

411

1.59

3.17

1.2

1.3

2.7

3.0

g/l

0.68

279

(3027135) IgG subclass 1 [Mass/volume] in Serum

411

1.59

3.17

1.2

1.3

6.3

6.9

g/l

1.07

278

(3024139) IgG subclass 3 [Mass/volume] in Serum

411

1.59

3.17

1.2

1.3

0.4

g/l

0.11

280

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

236

1.79

3.16

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1370

12595

1.12

3.13

4.9

4.8

1.9

3.1

ug/l

3.36

1214

11451

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1168

0.67

3.13

1.3

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.47

3.12

1.1

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

4.51

3.11

1.2

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

561

0.53

3.08

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

202

1.84

3.06

1.9

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

3.24

3.05

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.68

3.05

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1117

10164

1.13

3.04

4.5

4.1

21.9

21.7

0.13

490

4943

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.45

3.04

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

545

1.49

3.01

1.1

2.1

3.4

u/ml

0.88

248

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

521

1.50

3.00

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

233

1.77

2.99

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

204

1.82

2.98

1.9

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

220

2755

0.79

2.97

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

234

1.76

2.95

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.47

2.95

1.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

160

1219

1.32

2.92

3.0

2.5

3.6

g/l

0.22

149

1156

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

265

1.70

2.91

1.2

1.3

0.1

1.2

u/ml

1.75

122

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

155

1176

1.33

2.91

2.7

2.4

191.0

193.7

0.14

141

1131

(3036489) Thrombin time

198

1554

1.28

2.90

2.1

1.9

21.9

21.5

0.26

174

1362

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

397

1.57

2.90

1.0

1.1

—

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

774

0.62

2.87

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

527

1.49

2.86

1.6

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

207

1.79

2.85

2.6

2.1

20.8

119.4

ug/min

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

282

1.67

2.85

1.3

1.4

58.0

59.5

pmol/l

0.03

(3011648) Oxygen content in Venous blood

315

1.63

2.78

1.6

2.1

11.2

0.00

315

(3019225) pH of Specimen

464

3997

1.18

2.77

3.4

4.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

502

0.54

2.76

1.9

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.31

2.74

1.1

0.5

0.7

umol/24h

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

278

1.66

2.73

1.7

1.6

2.7

6.0

u/l

1.54

126

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.98

2.69

2.0

2.5

—

(3045716) Anion gap in Serum or Plasma

161

1.87

2.65

2.2

2.5

8.9

9.1

mmol/l

0.06

127

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

265

1.67

2.65

1.3

1.6

35.4

18.9

u/ml

—

(3014271) Vancomycin [Susceptibility]

154

1.89

2.65

3.1

2.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

140

1.93

2.64

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

289

1.63

2.62

1.8

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

203

1623

1.26

2.60

3.5

3.6

518.7

3431.5

u/ml

1.00

168

1411

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

443

1.50

2.54

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

1.68

2.50

1.9

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

194

1.76

2.50

1.1

u/l

0.42

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

128

970

1.33

2.48

2.1

2723.4

4637.4

u/l

0.32

397

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.81

2.46

1.5

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

109

2.02

2.45

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.55

2.44

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

280

1.61

2.42

1.6

1.8

8.0

6.7

mmol/l

0.88

181

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

143

1105

1.30

2.42

2.2

2.0

10.7

11.2

mg/l

0.36

131

1017

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

234

1.67

2.41

2.2

1.5

4.6

6.7

u/l

1.83

198

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

521

4583

1.15

2.40

3.6

4.2

38.9

35.5

ug/l

0.06

408

3683

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

268

1.61

2.31

1.0

1.1

224.7

285.5

mg/l

2.60

234

(3019897) Erythrocyte distribution width [Ratio] by Automated count

586

0.61

2.31

2.9

2.6

13.3

13.2

0.19

576

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

276

1.60

2.30

1.1

1.2

35.0

43.7

mg/l

1.08

232

(3008898) HLA-B27 [Presence]

165

1308

1.27

2.30

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

671

1.38

2.30

1.6

1.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

177

1.76

2.29

2.7

3.1

21.3

23.3

mu/l

0.18

171

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

277

1.59

2.27

2.4

2.7

915.4

655.4

e6/l

0.91

115

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

431

1.47

2.24

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

164

1304

1.27

2.24

2.3

2.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

263

1.60

2.23

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

179

1.74

2.22

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

392

1.48

2.20

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

100

2.00

2.20

1.3

1.2

330.3

284.5

pmol/l

0.19

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

264

1.60

2.20

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.41

2.19

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

2.18

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

526

1.41

2.17

1.1

1.5

g/l

0.17

472

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

297

1.55

2.16

1.2

1.0

289.7

288.2

mg/l

0.06

273

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

485

1.43

2.15

1.4

1.6

52.4

55.7

0.21

310

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

115

1.92

2.15

1.2

2.4

0.6

1.1

ug/l

1.30

105

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

162

1294

1.26

2.15

2.4

2.1

90.1

91.1

0.16

148

1216

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

1.83

2.13

2.4

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

339

1.51

2.11

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

160

1.75

2.09

1.1

—

382.1

—

(3045414) Leukocytes [Presence] in Urine

223

1853

1.21

2.06

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

398

1.46

2.06

5.6

4.8

6.5

7.2

mmol/l

1.34

333

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

136

1071

1.28

2.04

3.1

2.9

1.5

1.6

mg/l

0.50

120

985

(3004451) EKG impression Narrative

184

1.69

2.04

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

254

1.58

2.03

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.08

2.01

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.08

2.01

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.96

1.99

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

658

1.34

1.93

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.45

1.93

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

258

1.55

1.91

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.24

1.90

1.5

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

140

1119

1.26

1.88

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1.61

1.85

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

100

1.90

1.85

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

655

1.33

1.84

1.2

1.3

18.2

35.9

u/l

2.38

574

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

229

1.58

1.84

1.1

1.4

—

31.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

403

0.59

1.81

1.3

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

191

1.63

1.80

1.5

1.7

2.8

3.8

u/field

0.24

123

(3012565) Volume of 24 hour Urine

199

1.61

1.79

1.7

2.3

1772.9

1923.8

0.48

179

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

1.79

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

287

1.50

1.79

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

666

0.69

1.77

1.3

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.87

1.75

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

489

1.37

1.74

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.34

1.74

1.3

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

178

1.63

1.72

4.0

4.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.92

1.72

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1041

0.76

1.72

4.7

4.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.29

1.70

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

752

1.30

1.70

1.2

281.2

280.0

u/ml

0.02

492

(21494815) CD4 cells/100 lymphocytes in Specimen

332

1.45

1.69

2.2

2.3

43.0

39.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

164

1.65

1.67

1.3

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

1.83

1.67

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

417

1.40

1.66

4.5

5.5

21.3

95.1

u/ml

2.76

133

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.45

1.66

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.45

1.66

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

325

1.45

1.66

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

327

3720

0.87

1.66

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.58

1.65

2.1

1.8

34.4

46.6

umol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

520

1.35

1.65

1.6

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.80

1.65

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

572

1.33

1.65

1.7

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

418

1.39

1.64

2.0

1.8

3104.0

1410.5

titre

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

220

1.55

1.64

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

100

783

1.28

1.63

1.5

1.8

0.9

0.8

nmol/l

0.81

673

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

108

854

1.27

1.63

1.1

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

157

1295

1.22

1.63

1.6

1.0

6.8

iu/ml

0.62

277

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.44

1.62

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.44

1.62

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.44

1.62

1.3

1.2

—

(4027681)

205

1.56

1.62

1.3

1.2

—

(4038314)

3.57

1.61

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.15

1.61

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

706

1.29

1.60

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

480

1.36

1.60

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

480

1.36

1.60

1.2

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

262

1.49

1.60

2.1

2.6

548.4

552.9

e6/l

0.02

225

(3051611) Lipemic interference index of Serum or Plasma

412

1.39

1.60

2.5

3.3

—

(3011412) CD3 cells [#/volume] in Blood

379

1.40

1.58

2.3

2.4

1.3

1.1

e9/l

0.35

234

(3002619) Bacteria identified in Specimen by Culture

2.03

1.54

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.43

1.53

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1112

11814

0.93

1.52

1.3

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

100

1.80

1.52

5.7

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.59

1.51

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

478

0.67

1.50

2.4

2.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

452

1.35

1.49

1.0

4.0

2.9

u/ml

0.20

166

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

170

1.59

1.48

1.2

1.1

138.0

184.3

iu/ml

0.68

170

(3025468) Yersinia sp identified in Specimen by Organism specific culture

479

1.34

1.47

1.2

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

925

0.76

1.47

3.4

3.1

28.0

27.5

mg/l

0.04

580

(3010144) Erythrocytes [#/volume] in Synovial fluid

368

1.39

1.46

1.3

1.4

70914.9

64850.3

e6/l

0.05

244

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

481

1.33

1.44

1.2

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.73

1.43

1.5

1.3

56.9

14.5

pmol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.04

1.43

2.4

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

491

1.33

1.41

1.2

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

337

1.40

1.41

1.2

—

46.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

371

1.38

1.41

2.3

2.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

312

1.41

1.40

1.2

2.8

8.8

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

1.75

1.40

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

611

0.72

1.40

1.2

1.4

—

(3000012) Reticulocyte production index

213

1.51

1.40

1.7

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

185

1577

1.18

1.39

1.8

1.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

238

1.47

1.39

1.1

1.4

—

275.0

—

(3013762) Body weight Measured

2.94

1.36

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

215

1.49

1.35

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

426

1.34

1.7

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

487

1.32

1.34

1.2

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

619

1.28

1.33

1.3

1.2

3.8

4.8

u/ml

0.51

275

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

282

1.42

1.33

2.0

2.1

—

(4015189)

1.78

1.32

2.0

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

620

1.28

1.32

1.0

1.1

6.0

4.6

u/ml

0.24

286

(3010726) Horse dander IgE Ab [Units/volume] in Serum

550

1.29

1.31

1.0

1.3

1.9

u/ml

0.25

133

(3035285) Chloride [Moles/volume] in Venous blood

487

0.70

1.31

2.3

2.2

104.1

105.5

mmol/l

0.82

480

(3041354) Potassium [Moles/volume] in Venous blood

487

0.70

1.31

2.3

2.2

4.0

mmol/l

0.15

480

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

613

0.73

1.29

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

613

0.73

1.29

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

612

0.73

1.28

1.2

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.89

1.28

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

155

1313

1.19

1.28

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.29

1.26

1.0

—

(3042631) Mycobacterium sp identified in Specimen

536

1.29

1.26

3.1

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

894

1.22

1.26

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

252

1.43

1.26

2.3

3.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

205

1780

1.16

1.25

3.7

3.2

25.8

25.3

mmol/l

1.15

205

1723

(3050794) Legionella sp Ab [Presence] in Serum

2.22

1.24

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

609

1.27

1.23

1.7

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.91

1.22

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

762

1.24

1.22

1.6

1.5

116.7

117.7

u/ml

0.04

162

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

272

2416

1.13

1.21

2.7

3.8

41.4

56.6

u/ml

0.71

262

2326

(3004616) Nuclear Ab [Presence] in Serum

514

1.29

1.20

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.31

1.18

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.31

1.18

2.8

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

167

1435

1.17

1.18

1.8

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

685

1.24

1.17

1.1

1.5

u/ml

0.43

245

(44813793)

273

1.39

1.17

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

215

1.44

1.15

1.1

2.3

2.2

u/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

705

1.24

1.15

3.5

2.9

0.8

nmol/l

0.21

537

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

1.15

0.0

4.7

—

(3019977) pH of Arterial blood

199

1.46

1.14

2.0

2.5

7.4

0.29

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.34

1.12

1.0

1.2

12.4

20.5

u/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

835

1.21

1.11

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

799

1.22

1.11

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

424

1.30

1.09

1.3

1.4

23927.1

45091.4

e6/l

0.77

234

(3045424) Erythrocytes [Presence] in Urine

701

1.23

1.09

1.6

1.5

—

(4306422)

629

1.24

1.09

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

514

0.74

1.08

1.2

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

140

0.50

1.08

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

433

0.71

1.08

1.1

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

113

948

1.20

1.08

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

121

1426

0.84

1.06

1.8

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

622

1.24

1.06

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.62

1.05

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

587

1.25

1.05

1.0

1.9

1.2

u/ml

0.39

223

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.05

1.7

2.9

1.3

0.5

u/field

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.12

1.05

1.1

1.2

1.5

1.7

umol/24h

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

499

0.74

1.05

1.2

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

170

1.47

1.04

5.8

5.3

77.8

60.1

mg/l

0.75

128

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

446

1.28

1.03

1.1

94.1

96.4

0.26

420

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

179

1.45

1.02

1.0

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

140

1623

0.86

1.02

4.1

5.3

0.9

0.05

133

1509

(3037121) Protein [Mass/volume] in Urine

158

1373

1.16

1.00

3.2

3.1

0.2

0.3

g/l

2.07

569

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

110

929

1.19

0.99

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.57

0.99

1.2

1.1

96.2

84.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

175

1535

1.14

0.98

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

4.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.97

0.0

1.1

—

4.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

594

1.23

0.97

1.1

123.3

117.0

0.73

539

(3014599) Egg white IgE Ab [Units/volume] in Serum

216

1.39

0.95

1.1

1.0

1.2

0.4

u/ml

—

(3000330) Specific gravity of Urine by Test strip

185

2089

0.88

0.94

3.4

3.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.78

0.94

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.89

0.94

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

1.61

0.93

1.3

1.4

109.1

50.7

mu/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.22

0.93

1.7

1.3

—

(3010503) CD19 cells [#/volume] in Blood

243

1.36

0.92

2.8

2.5

0.1

0.2

e9/l

0.39

238

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.73

0.92

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.82

0.92

1.3

—

(3005033) Fetal Nuchal fold Thickness US

497

0.76

0.90

1.2

1.4

—

(3016750) Collection duration of Urine

227

1.37

0.90

2.6

2.2

506.2

495.6

min

0.22

167

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

429

1.26

0.89

1.3

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

673

1.21

0.89

1.2

—

(4146454)

421

1.26

0.88

2.5

2.6

—

(3014051) Protein [Presence] in Urine by Test strip

111

951

1.17

0.88

2.0

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

194

1.39

0.88

1.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

194

1.39

0.88

1.2

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

1.51

0.88

1.3

1.6

10.2

8.8

ug/l

0.51

119

(3014133) Dog dander IgE Ab [Units/volume] in Serum

485

1.24

0.87

1.1

1.0

2.3

2.4

u/ml

0.03

178

(3003577) Lead [Moles/volume] in Blood

2.00

0.87

1.2

1.4

—

0.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

325

1.29

0.86

1.2

1.3

10.6

12.7

mmol/l

0.83

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

178

1.41

0.86

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

495

1.24

0.85

2.4

2.2

14.5

24.6

mg/l

1.43

126

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

120

1.50

0.85

2.9

3.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.94

0.84

1.0

1.2

—

(4212803)

1.94

0.84

1.0

—

(3015183) Erythrocyte sedimentation rate

203

0.64

0.84

1.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

371

1.27

0.83

1.3

1.4

6.2

6.3

mmol/l

0.05

344

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

144

1633

0.88

0.81

4.0

5.2

1.8

1.6

1.22

138

1516

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

249

0.68

0.81

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.88

0.81

3.0

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.65

0.81

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

173

1542

1.13

0.80

2.2

2.0

1.2

2.1

ug/l

0.80

156

1389

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

303

1.29

0.79

2.0

2.1

14.7

15.3

0.08

132

(3017732) Neutrophils [#/volume] in Blood

316

2916

1.09

0.76

2.5

2.7

4.0

4.1

e9/l

0.44

236

2297

(4211845)

217

1.34

0.76

2.9

3.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

217

1.34

0.76

1.1

14.3

29.5

u/l

2.09

167

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.08

0.74

1.2

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

1.35

0.74

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

514

1.21

0.74

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

781

7451

1.06

0.74

3.1

2.9

0.6

0.8

ug/l

4.19

548

4873

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

108

1.48

0.73

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

634

1.19

0.73

1.3

1.2

2.4

3.6

u/ml

0.49

211

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

219

1.33

0.73

1.1

1.2

73.9

90.5

u/l

0.91

172

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

445

0.79

0.71

2.1

2.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.92

0.70

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

257

1.29

0.68

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

118

0.59

0.67

1.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.79

0.66

1.0

1.5

2.8

0.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

839

1.15

0.64

1.6

1.4

—

17.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

129

1150

1.12

0.64

1.3

157.8

219.2

miu/ml

1.26

529

(40768793) Breast Pathology biopsy report

122

1084

1.13

0.64

1.4

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

227

2089

1.09

0.62

2.4

2.6

0.3

e6/l

0.30

220

2044

(3029634) Reagin Ab [Titer] in Serum by VDRL

517

1.18

0.61

2.8

2.1

2.5

11.9

titre

—

(3023199) Leukocytes [#/volume] in Pleural fluid

471

1.19

0.61

1.3

1.4

19725.1

2010.6

e6/l

0.51

334

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.57

0.60

6.3

5.9

73.1

46.2

ug/min

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.50

0.59

1.1

1.0

—

(4024509)

390

1.21

0.59

1.9

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.40

0.58

1.3

1.2

110.2

85.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.58

0.0

1.1

—

(3012441) Differential panel - Pleural fluid

400

1.20

0.58

1.2

1.4

—

(3045788) Cell count panel - Pleural fluid

373

1.21

0.57

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.72

0.57

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.48

0.57

1.1

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.57

0.56

1.2

2.1

—

(3048879) Bone marrow aspiration report

122

0.66

0.54

1.1

2.3

—

(3006462) Nitrate [Presence] in Urine

204

1.28

0.54

2.8

3.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

138

1252

1.10

0.53

3.0

3.5

48.9

55.2

mg/l

0.21

112

1040

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.48

0.53

1.3

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

395

1.19

0.53

1.0

1.5

0.4

u/ml

0.33

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

160

1.31

0.53

2.4

2.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.54

0.53

1.0

2.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.43

0.53

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

907

0.88

0.52

4.9

7.4

106.0

105.3

mmol/l

0.67

800

(3039000) Anion gap in Blood

906

0.88

0.51

4.9

7.4

10.8

11.2

mmol/l

0.60

799

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

109

1.38

0.50

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

375

0.83

0.46

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

533

1.15

0.45

1.3

1.5

36.0

33.1

g/l

1.07

482

(3001019) Free T4 and TSH panel - Serum or Plasma

221

2068

1.07

0.45

1.9

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.40

0.45

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.40

0.45

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.40

0.45

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

283

1.20

0.44

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.40

0.44

1.5

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.45

0.44

1.0

6.3

9.0

mg/g

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

121

1.32

0.44

2.1

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

157

1.27

0.43

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

136

1251

1.09

0.43

3.0

3.5

28.5

55.1

mg/l

1.79

110

1037

(3017704) Immunofixation for Urine

218

0.78

0.42

1.9

1.6

—

(3004775) Volume in Urine collected for unspecified duration

322

1.18

0.42

2.6

2.3

800.4

644.7

0.71

211

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

150

0.73

0.41

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

294.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.41

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.7

—

400.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

132

1216

1.09

0.41

3.0

3.4

1.2

2.3

ratio

—

112

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

249

0.80

0.40

1.1

1.0

ratio

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.40

0.0

1.6

—

2.1

—

(3033799) Differential panel - Peritoneal fluid

149

0.74

0.40

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

343

1.17

0.39

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

343

1.17

0.39

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

343

1.17

0.39

1.4

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

702

1.11

0.39

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.39

0.0

1.1

—

(40768446) Kidney Pathology biopsy report

160

1.25

0.38

1.2

1.7

—

(3001729) Color of Synovial fluid

1.39

0.38

1.0

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.32

0.37

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

235

0.81

0.36

1.1

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.29

0.36

1.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

821

1.10

0.36

1.5

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

126

1.27

0.35

2.6

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

329

1.16

0.35

1.3

2.1

5.0

8.9

umol/l

1.27

234

(3000034) Microalbumin [Mass/volume] in Urine

404

0.87

0.33

3.6

2.9

10.8

69.6

mg/l

2.24

291

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

154

1.23

0.33

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

243

0.82

0.33

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

467

0.88

0.33

3.8

3.5

22.5

46.1

u/ml

2.90

461

(3042111) Morphology [Interpretation] in Bone marrow Narrative

692

1.10

0.33

1.3

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.67

0.33

1.3

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

341

1.14

0.32

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

183

1.20

0.31

1.1

1483.7

1509.9

miu/ml

0.04

183

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

737

0.91

0.31

1.4

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

101

935

1.08

0.31

3.0

3.6

296.1

386.4

u/ml

0.20

849

(3037692) Legionella sp identified in Specimen by Organism specific culture

164

0.79

0.30

1.1

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

164

0.79

0.30

2.3

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

142

0.77

0.30

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.30

1.6

2.5

—

(3022689) Creatine [Moles/volume] in Urine

129

1.24

0.30

1.1

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

941

0.92

0.29

3.3

3.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

517

5319

0.97

0.27

4.7

4.4

31.0

32.8

3.14

363

3586

(3042733) HLA Ab [Presence] in Serum

149

1.21

0.27

4.2

5.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

117

1097

1.07

0.27

1.3

—

(4133840)

121

0.74

0.27

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

104

1.25

0.26

1.5

2.1

1.5

2.4

ug/l

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

104

1.25

0.26

1.3

40.7

36.4

—

(40768795) Lymph node Pathology biopsy report

468

0.90

0.26

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.69

0.26

1.8

1.6

110.8

146.4

ng/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.69

0.26

3.2

2.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

138

0.80

0.25

2.7

6.4

26.2

25.2

mmol/l

0.18

127

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

396

1.11

0.25

1.3

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.26

0.24

1.1

1.5

—

106.8

titre

—

(3024263) Appearance of Synovial fluid

218

1.15

0.23

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.28

0.23

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.28

0.23

2.0

1.9

1.5

1.7

mg/l

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

336

0.89

0.21

1.7

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.19

0.21

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

2.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

14.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

165

1.15

0.19

2.6

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

137

1.17

0.18

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

100

1.20

0.18

1.3

1.4

—

33.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.11

0.17

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.75

0.17

1.4

2.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

120

0.83

0.16

1.2

2.0

15.6

49.8

u/l

—

111

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

101

1.19

0.16

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.14

0.16

1.3

1.5

—

(44806420)

111

1.17

0.15

2.3

2.4

—

(40757373) Influenza virus identified in Isolate

1.10

0.15

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

151

0.86

0.15

1.6

1.8

366.8

26012.8

e6/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

193

0.88

0.15

1.4

1.5

8.9

7.9

mmol/l

0.66

123

(4035726)

415

4067

1.02

0.15

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

409

1.08

0.15

1.3

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

332

1.08

0.15

1.6

1.4

2.8

4.5

ug/l

0.82

259

(21494434) Karyotype in Bone marrow

369

0.92

0.15

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

178

1.12

0.15

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

178

1.12

0.15

1.1

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.15

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

131

1.15

0.14

1.3

1.4

—

(4268621)

440

1.07

0.14

2.6

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

149

0.87

0.13

1.2

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

209

1.10

0.13

2.4

2.2

214.4

201.5

u/l

0.21

209

(40768800) Prostate Pathology biopsy report

803

0.96

0.11

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

621

1.05

0.11

1.1

1031.0

iu/ml

0.57

134

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

157

0.89

0.11

1.1

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

167

0.90

0.10

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

643

1.04

0.10

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

106

1.13

0.09

1.6

2.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.09

0.09

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

566

1.04

0.09

1.3

1.2

7.3

7.4

mmol/l

0.04

432

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

311

1.06

0.09

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

1.08

0.09

1.8

3.4

—

(3044007) Cell count panel - Peritoneal fluid

134

0.90

0.08

2.0

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.07

0.08

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.82

0.07

1.0

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

1.11

0.07

1.8

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

1.11

0.07

1.8

2.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.05

0.07

2.3

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.05

0.07

4.7

6.3

—

(40768441) Liver Pathology biopsy report

324

1.05

0.07

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

236

1.06

0.06

1.1

1.4

—

(40768806) Pleura Pathology biopsy report

424

1.04

0.06

1.3

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

141

0.92

0.05

2.8

3.7

50.3

50.0

0.01

132

(3013637) Mi-2 Ab [Presence] in Serum

101

1.09

0.04

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

101

1.09

0.04

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

101

1.09

0.04

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

101

1.09

0.04

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

646

1.02

0.04

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

402

0.97

0.04

4.2

3.9

62.1

57.8

0.50

262

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

220

1.05

0.03

9.0

5.1

35.6

17487.3

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

883

0.99

0.03

3.8

5.6

131.5

472.9

iu/ml

—

121

(3004809) Band form neutrophils/100 leukocytes in Blood

672

0.98

0.03

3.6

3.7

1.8

1.5

0.25

517

(3037556) Urate [Mass/volume] in Serum or Plasma

118

0.93

0.02

1.5

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

1.07

0.02

1.4

1.2

—

(40765096) Chromosome analysis panel by Banding

128

0.94

0.02

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

126

1247

1.01

0.02

4.1

6.4

1.2

1.3

mmol/l

1.35

115

1086

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

232

1.03

0.02

1.1

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

103

1.07

0.02

1.1

1.4

17.8

20.1

0.18

(3028433) Virus identified in Specimen by Culture

137

0.95

0.01

1.1

—

(44790049)

462

1.02

0.01

1.4

—

(44806118)

462

1.02

0.01

1.4

—

(44790048)

462

1.02

0.01

1.4

—

(44790047)

462

1.02

0.01

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

267

0.97

0.01

1.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

423

1.02

0.01

4.5

4.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

414

1.01

0.00

1.6

1.3

—

(3034426) Prothrombin time (PT)

148

1.01

0.00

1.2

—

(3035880) pH of Pleural fluid

222

0.99

0.00

1.5

1.3

—

(3020650) Glucose [Presence] in Urine

115

0.96

0.00

1.5

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

278

1.01

0.00

1.4

1.7

—

(3047189) Immunofixation for 24 hour Urine

195

0.97

0.00

1.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

205

0.98

0.00

1.5

2.0

—

(3022621) pH of Urine by Test strip

271

2712

1.00

0.00

3.2

2.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

0.97

0.00

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

164

0.98

0.00

1.5

2.0

37677.0

5562.4

e6/l

—

112

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

164

0.98

0.00

1.6

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

103

0.97

0.00

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

204

0.98

0.00

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

204

0.98

0.00

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

204

0.98

0.00

1.5

2.0

—

(3024932) HLA-DR beta [Type]

147

1.02

0.00

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

1.02

0.00

2.9

2.7

—

(4281824)

544

0.99

0.00

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

503

0.99

0.00

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.1

—

(3024471) HLA-A [Type]

151

0.99

0.00

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

179

1.01

0.00

11.7

13.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

1.00

0.00

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

309

1.00

0.00

7.7

6.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

319

1.00

0.00

1.6

1.9

2.4

1.9

u/field

0.21

112

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.95

0.00

1.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

120.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

160

1.00

0.00

1.6

2.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

160

1.00

0.00

1.6

2.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.91

0.00

4.2

2.3

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

2.3

—

0.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.93

0.00

1.3

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.98

0.00

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.92

0.00

3.0

2.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.4

—

2.9

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

38.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

12.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.91

0.00

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(44806071)

1.00

0.00

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.91

0.00

1.2

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Monoamine oxidase A inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Monoamine oxidase A inhibitors (MAOI_A)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints